Cardiovascular diseases as a cause of mortality in Poland – a trend analysis

```html

Streszczenie

Choroby układu krążenia stanowią wiodącą przyczynę zgonów w Polsce i na świecie. Celem pracy jest analiza trendów umieralności z powodu chorób sercowo-naczyniowych w Polsce w latach 1990–2020 oraz identyfikacja czynników kształtujących te trendy. W rozdziale pierwszym omówiono definicje i klasyfikacje chorób układu krążenia, globalne obciążenie umieralnością sercowo-naczyniową oraz charakterystykę epidemiologiczną tej umieralności w Polsce, a także metodologiczne podstawy analizy trendów czasowych. Rozdział drugi poświęcono determinantom umieralności sercowo-naczyniowej w populacji polskiej — behawioralnym, metabolicznym, społeczno-ekonomicznym oraz wynikającym z organizacji systemu ochrony zdrowia. W rozdziale trzecim przeprowadzono temporalną analizę trendów umieralności ogólnej i przyczynowo swoistej, ze szczególnym uwzględnieniem choroby niedokrwiennej serca i chorób naczyniowych mózgu oraz przedwczesnej umieralności wyrażonej utratą lat życia. Wykazano, że Polska odnotowała znaczący i trwały spadek standaryzowanych współczynników umieralności sercowo-naczyniowej, jednak zmiana ta nie przebiegała równomiernie w całej populacji. Kluczową rolę odegrały zmiany populacyjnych czynników ryzyka — ograniczenie palenia tytoniu i modyfikacja nawyków żywieniowych — a także rozbudowa dostępności procedur kardiologicznych i programów profilaktycznych.^{[12, s. 143]} Utrzymujące się różnice względem Europy Zachodniej wskazują na niekompletny charakter przejścia epidemiologicznego i konieczność kontynuacji systemowych działań prozdrowotnych.

Słowa kluczowe: choroby układu krążenia, umieralność, trendy epidemiologiczne, czynniki ryzyka sercowo-naczyniowego, profilaktyka, Polska

Abstract

Cardiovascular diseases constitute the leading cause of death in Poland and worldwide. The aim of this thesis is to analyse trends in cardiovascular mortality in Poland over the period 1990–2020 and to identify the factors shaping these trends. The first chapter addresses the definitions and classification of cardiovascular diseases, the global burden of cardiovascular mortality, the epidemiological characteristics of this mortality in Poland, and the methodological foundations of temporal trend analysis. The second chapter examines the determinants of cardiovascular mortality in the Polish population, including behavioural, metabolic, socioeconomic, and healthcare system factors. The third chapter presents a temporal analysis of overall and cause-specific mortality trends, with particular attention to ischaemic heart disease and cerebrovascular disease, as well as premature cardiovascular mortality expressed in years of life lost. It is demonstrated that Poland achieved a substantial and sustained reduction in age-standardised cardiovascular death rates over the observation period; however, this decline was neither uniform in pace nor equitable in its distribution across the population. The most consequential drivers of mortality reduction included changes in population-level risk factors — notably declining tobacco smoking rates and dietary pattern shifts — alongside the expansion of interventional cardiology capacity and structured prevention programmes. The persistent gap relative to Western European benchmarks underscores the incomplete character of the epidemiological transition and the continued need for systematic public health investment.

Keywords: cardiovascular diseases, mortality, epidemiological trends, cardiovascular risk factors, prevention, Poland

```

List of Abbreviations

AAPC

average annual percentage change

AMI

acute myocardial infarction

ASDR

age-standardised death rate

BMI

body mass index

CEE

Central and Eastern Europe

CI

confidence interval

CVD

cardiovascular disease

FSU

former Soviet Union

GBD

Global Burden of Disease

GUS

Główny Urząd Statystyczny (Central Statistical Office)

HAPIEE

Health, Alcohol and Psychosocial Factors in Eastern Europe

HDL

high-density lipoprotein

HR

hazard ratio

ICD-10

International Classification of Diseases, Tenth Revision

ICD-11

International Classification of Diseases, Eleventh Revision

IHD

ischaemic heart disease

KOS-MI

Koordynowana Opieka po zawale Mięśnia sercowego (Coordinated Care Programme after Myocardial Infarction)

LDL

low-density lipoprotein

MACAMIS

Managed Care for Acute Myocardial Infarction Survivors

MACCE

major adverse cardiovascular and cerebrovascular events

NATPOL

Nationwide Survey of Cardiovascular Risk Factors

NFZ

Narodowy Fundusz Zdrowia (National Health Fund)

NIZP

Narodowy Instytut Zdrowia Publicznego (National Institute of Public Health)

ORPKI

Ogólnopolski Rejestr Procedur Kardiologii Interwencyjnej

PARPA

Państwowa Agencja Rozwiązywania Problemów Alkoholowych

PCI

percutaneous coronary intervention

POLKARD

National Programme for Prevention and Treatment of Cardiovascular Diseases

POZ

podstawowa opieka zdrowotna (primary healthcare)

pPCI

primary percutaneous coronary intervention

PTK

Polskie Towarzystwo Kardiologiczne (Polish Society of Cardiology)

PYLL

Potential Years of Life Lost

SES

socioeconomic status

SEYLL

Standard Expected Years of Life Lost

SEYLLd

standardised expected years of life lost per death

STEMI

ST-elevation myocardial infarction

TC

total cholesterol

WHO

World Health Organization

WOBASZ

Multi-Centre National Population Health Examination Survey

Introduction

Cardiovascular diseases represent the foremost cause of mortality across the contemporary world, accounting for a greater proportion of all deaths than any other category of non-communicable disease. The global burden of cardiovascular mortality encompasses a broad spectrum of pathological conditions — including ischaemic heart disease, cerebrovascular disease, heart failure, and peripheral arterial disease — each of which exerts a distinct epidemiological footprint across different populations, age groups, and socioeconomic contexts. While the aggregate mortality burden attributable to cardiovascular disease has declined substantially in many high-income countries over the second half of the twentieth century, this decline has been neither universal nor uniform. Significant disparities persist both between world regions and within national populations, reflecting the uneven distribution of risk factor exposure, health system capacity, and the pace at which evidence-based preventive and therapeutic strategies have been implemented across different social strata.

Within the European context, the epidemiological experience of Poland occupies a particularly instructive position. At the beginning of the 1990s, Poland bore one of the highest cardiovascular mortality burdens in Europe — a burden shaped by decades of unfavourable population-level risk factor profiles, including high prevalences of tobacco smoking, diets rich in animal fats, physical inactivity, and uncontrolled hypertension, as well as by the structural inadequacies of a health system that had inherited the institutional legacy of the socialist period. The transition to a market economy following 1989 initiated a series of transformations — in dietary habits, in living standards, in health system organisation, and in the availability of pharmacotherapeutic agents — that collectively generated a profound and sustained shift in the cardiovascular mortality trajectory of the Polish population. The magnitude and speed of the subsequent decline in cardiovascular death rates were remarkable by international standards, yet the persistence of a substantial gap relative to Western European comparators at the close of the observation period attests to the incomplete character of this epidemiological transition and to the continued presence of modifiable determinants that have not been adequately addressed.

The analysis of mortality trends over time occupies a central methodological position in epidemiology and public health, because longitudinal data on cause-specific death rates provide one of the most reliable available measures of the aggregate health impact of both risk factor change and health system performance. Trend analysis enables the identification of inflection points — moments at which the trajectory of mortality acceleration or deceleration shifts — that can be associated with specific policy interventions, economic transitions, or changes in population behaviour. In the Polish case, the availability of mortality registry data spanning the post-transformation period provides an opportunity to examine the relationship between the structural transformations of the 1990s and the observed patterns of cardiovascular mortality decline with a level of empirical specificity that cross-sectional analyses cannot achieve. The temporal dimension of the analysis is moreover essential for distinguishing changes in the crude burden of cardiovascular deaths — which are substantially influenced by population ageing — from changes in age-standardised rates, which reflect genuine shifts in the underlying risk of cardiovascular death independent of demographic composition.

The present thesis is concerned with cardiovascular diseases as the leading cause of mortality in Poland, examined through the lens of trend analysis over the three decades from 1990 to 2020. The primary aim of the thesis is to characterise the temporal trajectory of cardiovascular mortality in the Polish population during this period, to identify the principal determinants and risk factors that have shaped this trajectory, and to situate the Polish experience within the broader European and global context. The specific objectives of the thesis are fourfold: first, to establish the theoretical and conceptual framework within which cardiovascular mortality and its measurement are understood, with particular attention to the epidemiological tools employed in trend analysis and international comparison; second, to examine the multilevel determinants — behavioural, metabolic, socioeconomic, and systemic — that have contributed to the elevated historical burden of cardiovascular mortality in Poland and to its subsequent reduction; third, to analyse the empirical trends in cardiovascular mortality in Poland between 1990 and 2020, disaggregated by major cardiovascular disease category, sex, and age group; and fourth, to derive public health implications from the observed trends that are relevant to contemporary preventive and health system policy in Poland.

The methodological approach adopted in this thesis is primarily descriptive and analytical, drawing on secondary data from national and international mortality registries and epidemiological surveillance systems. The analysis of mortality trends relies on age-standardised death rates, which adjust for differences in population age structure and thereby permit valid comparisons across time periods and between countries with divergent demographic profiles. The data sources consulted include mortality statistics compiled by national public health and statistical institutions, as well as European and global databases that provide harmonised cause-specific mortality estimates across countries and years. The conceptual framework employed in interpreting the multilevel determinants of cardiovascular mortality draws on established models in social epidemiology, including the Dahlgren–Whitehead model of the social determinants of health, which situates individual behavioural risk factors within the broader socioeconomic and structural contexts that shape their distribution across populations. The epidemiological concepts and analytical methods central to the thesis — including standardisation procedures, the concept of premature mortality, and the distinction between primary, secondary, and tertiary prevention — are introduced and elaborated in the first chapter, providing the conceptual vocabulary through which the empirical content of the subsequent chapters is interpreted.

The structure of the thesis reflects the logical sequence of the analytical objectives described above. The first chapter establishes the theoretical framework of the thesis by examining the global and European epidemiology of cardiovascular disease, introducing the demographic and epidemiological methods relevant to the analysis of mortality trends, and contextualising the Polish experience within the epidemiological transition paradigm. Attention is given to the methodological challenges inherent in cross-national mortality comparisons, including the influence of age composition, coding practices, and the completeness of vital registration systems on observed differences in cardiovascular death rates. The second chapter examines the determinants and risk factors of cardiovascular mortality in the Polish population, proceeding from proximate behavioural and metabolic risk factors — including tobacco use, dietary patterns, physical inactivity, hypertension, dyslipidaemia, and diabetes — to more distal socioeconomic determinants such as income inequality, educational attainment, occupational conditions, and regional disparities in health system access. The health system itself is examined as a structural determinant of cardiovascular mortality, with particular attention to the role of pharmaceutical availability, the organisation of emergency and primary care, and the implementation of population-level prevention programmes in shaping the observed mortality trends. The third chapter presents the empirical trend analysis, characterising the overall trajectory of cardiovascular mortality in Poland from 1990 to 2020, examining sex- and age-specific patterns of decline, and analysing trends separately for the major cardiovascular disease subcategories — ischaemic heart disease, cerebrovascular disease, and heart failure. The third chapter also situates the Polish trend within the European context by comparing the magnitude and pace of mortality decline with trends observed in Western European countries, and derives public health implications from the analysis that are relevant to the ongoing challenge of reducing preventable cardiovascular mortality in Poland.

The thesis addresses a question of enduring relevance to Polish public health. Despite the substantial progress achieved in reducing cardiovascular mortality since the early 1990s, cardiovascular diseases remain the leading cause of death in Poland, responsible for approximately half of all mortality in the population. The gap relative to Western European countries with the lowest cardiovascular death rates, while narrowed, has not been eliminated, and within-country inequalities in cardiovascular mortality risk by socioeconomic position, sex, and region persist. The analysis presented in this thesis seeks to contribute to an evidence-based understanding of the factors that have driven the observed mortality transition and of the barriers that continue to impede further progress — an understanding that is prerequisite to the rational design of preventive, clinical, and health system interventions capable of reducing the residual burden of premature cardiovascular death in the Polish population.

of the underlying age-specific mortality rates, population size, and age composition — factors that diverge substantially across world regions and that must be disentangled through demographic standardisation before valid cross-national comparisons can be drawn.

The global epidemiology of coronary heart disease — the largest single contributor to cardiovascular mortality — has followed markedly divergent trajectories across different world regions over the second half of the twentieth century. In most industrialised countries, coronary heart disease mortality rates have declined substantially, with rates approximately halving since the 1980s as a consequence of convergent improvements in cardiovascular risk factor profiles, acute clinical management, and secondary prevention pharmacotherapy.<sup>[1, s. 2]</sup> Modelling analyses conducted in industrialised countries have consistently attributed the larger share of coronary heart disease mortality reduction to population-level changes in risk factor prevalence rather than to improvements in treatment, illustrating the fundamental importance of primary prevention relative to clinical intervention in shaping aggregate mortality outcomes.<sup>[1, s. 2]</sup> The temporal pattern of decline has varied across countries: some nations experienced the most rapid reductions in the 1970s and 1980s following the initial implementation of structured cardiovascular prevention programmes, while others achieved steeper declines in the 1990s and 2000s as therapeutic innovations became more broadly accessible to their populations.

• Reduction in population-level tobacco smoking prevalence through legislative, fiscal, and educational interventions, removing the largest single modifiable risk factor from broad population exposure
• Dietary pattern improvements, particularly reductions in saturated fat consumption and increased fruit and vegetable intake, reducing population-mean cholesterol levels and atherogenic dietary load
• Pharmacological control of arterial hypertension, dyslipidaemia, and type 2 diabetes mellitus through wider access to and uptake of evidence-based medications including statins and antihypertensives
• Expansion of emergency coronary care including percutaneous coronary intervention and thrombolytic therapy, substantially reducing case fatality rates from acute myocardial infarction
• Development of cardiac rehabilitation programmes and secondary prevention protocols reducing recurrence rates and extending survival after acute cardiovascular events
• Improved socioeconomic conditions in many high-income countries, reducing chronic psychosocial stress exposure and occupational cardiovascular hazards

In contrast to the progress achieved in high-income countries, many low- and middle-income nations have experienced substantial increases in the absolute number of cardiovascular deaths as demographic transition advances population ageing faster than health systems develop the capacity to manage cardiovascular risk. Projections from the Global Burden of Disease (GBD) study indicate that coronary heart disease is anticipated to be the leading global cause of death and disability by 2020 and beyond, primarily as a consequence of rising absolute death counts in lower-income regions, even as age-standardised rates may eventually begin to fall in those settings as prevention measures develop.<sup>[1, s. 2]</sup> The divergence between high-income and low- and middle-income country trajectories underscores the importance of contextualising national mortality trends within the appropriate comparative framework, as the epidemiological determinants of cardiovascular mortality and the policy levers available to modify them differ substantially across development contexts.

Central and Eastern European countries, including Poland, occupy a distinctive and epidemiologically significant position in the global landscape of cardiovascular mortality. In contrast to the sustained decline observed in Western Europe since the 1970s, the countries of Central and Eastern Europe and the former Soviet Union (FSU) experienced increasing or stagnating cardiovascular mortality rates through much of the post-war period and into the early 1990s.<sup>[4, s. 2]</sup> This divergence produced a large and well-documented gap in life expectancy between Eastern and Western Europe, attributable in substantial part to the differential cardiovascular mortality burden, and constituted one of the most striking features of European health geography in the latter half of the twentieth century.<sup>[4, s. 2]</sup> The determinants of this East–West mortality divide have been extensively examined within the framework of the Health, Alcohol and Psychosocial Factors in Eastern Europe (HAPIEE) study — a major multinational cohort investigation encompassing populations in Poland, the Czech Republic, Russia, and Lithuania — which identified the combination of adverse behavioural risk factors, socioeconomic disadvantage, psychosocial stress, and limited access to effective cardiovascular care as the principal explanatory factors for the excess Eastern European mortality burden.<sup>[4, s. 2]</sup>

The geographical patterning of cardiovascular mortality across Europe is further complicated by substantial heterogeneity within the Central and Eastern European region itself. While some countries — notably Poland, Hungary, and the Czech Republic — achieved rapid and substantial reductions in cardiovascular mortality following the political and economic transitions of the early 1990s, others experienced dramatic mortality fluctuations, including acute crises in Russia and the Baltic states during the period of Soviet dissolution, with rates rising sharply before eventually declining as systemic stability was restored.<sup>[4, s. 2]</sup> These divergent trajectories within the Eastern European region challenge any simple characterisation of cardiovascular mortality dynamics in post-communist societies and underscore the importance of examining country-specific factors — including differences in the pace and nature of economic transition, healthcare reform, dietary change, and public health policy implementation — in any detailed national analysis.

Schematic representation of cardiovascular mortality trajectories by European region, 1970–2020

Western Europe (EU-15): Sustained decline from the 1970s onwards; lowest age-standardised CVD death rates in the European region by 2020; driven by early adoption of risk factor reduction strategies and advanced clinical care.

Central Europe (Poland, Czech Republic, Hungary): Increasing or plateau mortality through 1980s and into early 1990s, followed by steep and sustained decline after the political-economic transition; substantial gap with Western Europe narrowed but not closed.

Eastern Europe and FSU: Marked fluctuations including mortality crises in late 1980s–1990s; delayed and more modest decline; largest residual gap with Western European benchmarks persisting into the 2020s.

Note: Schematic based on European Health for All Database data trends and the HAPIEE study regional analysis; precise values vary by sex, age group, and specific CVD subcategory.

The comparative analysis of cardiovascular mortality across European Union member states reveals that, despite substantial progress in the countries of Central and Eastern Europe, a persistent excess mortality relative to Western European benchmarks remains a defining feature of the regional epidemiological landscape. Age-standardised cardiovascular death rates in Central and Eastern European countries consistently exceed those of Western European nations by margins that, while having narrowed considerably over the past two to three decades, continue to represent substantial differences in mortality risk for populations of equivalent age structure. This excess is concentrated particularly in younger and middle-aged adults — the age groups in whom cardiovascular death represents the largest departure from the mortality patterns of Western European comparators — and differs in magnitude between men and women, with men bearing a disproportionate share of the excess in most Central and Eastern European countries. Poland's position within this comparative framework, characterised by a trajectory of remarkable decline from very high baseline rates following the early 1990s transition but persistent excess relative to the EU-15 average, provides the central epidemiological context for the detailed national trend analysis developed in subsequent chapters and motivates examination of both the drivers of Poland's progress and the structural factors that sustain the residual mortality gap.

1.3. Epidemiological Characteristics of CVD Mortality in Poland

Cardiovascular diseases represent the dominant cause of mortality in Poland, a position they have maintained throughout the period covered by this analysis. As noted in studies of coordinated cardiac care programme outcomes in Poland, cardiovascular diseases account for approximately 46 per cent of all deaths in the country, making them the single most important cause-of-death category for both men and women and situating Poland among the European countries with the highest proportional cardiovascular mortality burden relative to total deaths. The scale of ischaemic heart disease specifically is considerable: approximately two million people in Poland suffer from ischaemic heart disease, representing approximately 5.5 per cent of the total population, with an average annual incidence estimated at between 250 and 300 new cases per 100,000 inhabitants, figures that define ischaemic heart disease as a mass population health problem demanding systemic public health responses beyond individual clinical management.

The historical trajectory of cardiovascular mortality in Poland follows a pattern that mirrors, with important country-specific variations, the broader regional narrative of the Central and Eastern European experience. The increase in cardiovascular mortality that characterised Poland from the mid-twentieth century continued through the early 1990s, reflecting the cumulative effect of decades of high exposure to major cardiovascular risk factors — including very high rates of tobacco smoking, diets with elevated saturated fat content and insufficient fruit and vegetable consumption, and increasing prevalence of arterial hypertension — combined with limited access to effective preventive and curative cardiology services comparable to those available in Western Europe.<sup>[2, s. 130]</sup> From the early 1990s, however, Poland experienced one of the most rapid and sustained declines in cardiovascular mortality of any country in the European region. Epidemiological analyses examining the relationship between dietary change and coronary heart disease mortality in Poland have identified the shift away from animal fats towards vegetable oils during and after the political transition as a key proximal determinant of the observed mortality reduction, demonstrating that population-level dietary change can produce measurable mortality benefits within a timeframe of years rather than decades.

The quantitative dimensions of Poland's cardiovascular mortality decline are well-documented by national vital statistics and epidemiological research. Between 1999 and 2018, standardised death rates from cardiovascular disease declined by an average of 2.8 per cent per year among men and 3.0 per cent per year among women in Poland, a pace of improvement that substantially narrowed the gap with Western European mortality levels while confirming the consistency of the trend across sex groups. A particularly pronounced decline in mortality from heart disease was observed in the 25 to 64 year age range — after 2014 for women and one year later for men — indicating that middle-aged and relatively younger adults disproportionately benefited from the combination of prevention campaigns, pharmacological risk factor management, and expanded acute care capacity. Research into premature cardiovascular mortality trends in Poland has confirmed that the most substantial mortality improvements have been concentrated in the age groups where cardiovascular death represents the greatest departure from Western European life expectancy norms.<sup>[10]</sup>

The decline in mortality attributable to acute myocardial infarction has been particularly pronounced and is amenable to precise quantification through the application of joinpoint regression analysis to nationwide mortality data. Analysis of AMI-specific standardised death rates demonstrates an average annual percentage change of −5.6 per cent over the period from 2000 to 2023, with the decline statistically significant and broadly continuous across the study period. Declines were slightly greater among men (−5.7 per cent annually) than women (−5.3 per cent annually), reflecting differences in the pace of risk factor change between the sexes but confirming a favourable direction for both groups. A temporary stagnation in the pace of AMI mortality decline was observed between 2017 and 2020, followed by renewed steep declines thereafter, suggesting the influence of systemic factors — including disruptions to preventive care access during the COVID-19 pandemic, altered patterns of healthcare-seeking behaviour, and excess cardiovascular mortality attributable directly to SARS-CoV-2 infection — on short-term mortality dynamics before the underlying long-term trend reasserted itself.

Table 1.2. Key indicators of acute myocardial infarction and overall cardiovascular mortality in Poland

Indicator	Value / Trend	Reference Period
CVD as proportion of all-cause mortality in Poland	Approximately 46%	Recent years
Estimated prevalence of IHD in Poland	Approx. 2 million persons (5.5% of population)	Recent estimates
Annual IHD incidence rate	250–300 new cases per 100,000 inhabitants	Recent estimates
Decline in standardised CVD death rates (men)	−2.8% per year on average	1999–2018
Decline in standardised CVD death rates (women)	−3.0% per year on average	1999–2018
Average Annual Percentage Change in AMI mortality (men)	−5.7% per year (statistically significant)	2000–2023
Average Annual Percentage Change in AMI mortality (women)	−5.3% per year (statistically significant)	2000–2023
Standard Expected Years of Life Lost (SEYLL) from AMI	From 608,488 (2000) to 191,476 (2023); >70% reduction	2000–2023
SEYLL per death (SEYLLd)	From 21.2 years (2000) to 16.9 years (2023)	2000–2023

The burden of premature cardiovascular mortality in Poland is further illuminated by analysis of years of life lost, a measure that weights deaths by their age at occurrence and thus captures the societal cost of mortality among younger age groups. The Standard Expected Years of Life Lost attributable to acute myocardial infarction in Poland decreased from 608,488 years in 2000 to 191,476 years in 2023, representing a reduction of more than 70 per cent across the study period, with similar relative declines documented for men and women. The average SEYLL per death declined from 21.2 years to 16.9 years across the same period, indicating that the age at death from AMI has shifted towards older age groups — a finding consistent with improved acute management and secondary prevention prolonging survival after myocardial infarction while not eliminating eventual cardiovascular death in long-term survivors. Research on fifteen-year mortality trends in Poland using SEYLL has confirmed the consistency of these improvements across multiple cardiovascular disease subcategories and across the major methodological variants of the years-of-life-lost framework.<sup>[11]</sup>

Sex-specific patterns in cardiovascular mortality in Poland reflect the broader European pattern of markedly higher rates in men than in women, with important age-group-specific nuances. Men in Poland consistently exhibit higher age-standardised cardiovascular death rates across all major CVD subcategories, with the differential particularly pronounced in the working-age population (35–64 years). In a regional epidemiological study of patients hospitalised with coronary artery disease in the Żywiec district of southern Poland, men accounted for the majority of coronary artery disease diagnoses; the condition was more prevalent among men, particularly in the 40 to 55 year age group, while among older individuals the sex-specific incidence rates converge more closely. The excess male cardiovascular mortality risk in Poland reflects the combined contribution of historically higher tobacco smoking prevalence among men, greater occupational exposures to cardiovascular risk factors, differences in the timely recognition and management of cardiovascular risk, and the well-established biological phenomenon of delayed onset of severe atherosclerosis in women relative to men during the pre-menopausal years.

• Cardiovascular diseases account for approximately 46 per cent of all deaths in Poland, the highest proportional burden among major cause-of-death categories
• Standardised cardiovascular death rates declined by 2.8–3.0 per cent annually between 1999 and 2018, one of the most sustained national declines in the European region
• AMI mortality declined by an average annual percentage change of −5.6 per cent between 2000 and 2023, with statistically significant trends in both sexes
• Standard Expected Years of Life Lost to AMI decreased by more than 70 per cent between 2000 and 2023, from 608,488 to 191,476 years
• Men bear a disproportionate cardiovascular mortality burden, particularly in the working-age population (35–64 years), across all major CVD subcategories
• A temporary stagnation in the pace of decline was documented between 2017 and 2020, followed by renewed acceleration thereafter
• Regional variation persists across Poland's sixteen voivodeships, with higher rates generally documented in eastern and south-eastern regions

Regional variation in cardiovascular mortality across Poland's sixteen voivodeships constitutes a significant and policy-relevant dimension of the national epidemiological picture. Studies of spatial variation consistently document a broad pattern of higher cardiovascular mortality in eastern and south-eastern regions relative to western and north-western voivodeships, although the magnitude and precise nature of this gradient have evolved as the pace of economic development, healthcare investment, and behavioural change has differed across regions. The comorbidity profile of patients presenting with ischaemic heart disease also varies across regions of Poland: in the regional epidemiological study conducted in the Żywiec district of southern Poland, hypertension was identified as the most common comorbid condition, affecting 67 per cent of patients with coronary artery disease, most of whom had not previously experienced myocardial infarction, confirming the fundamental and clinically well-established association between arterial hypertension and the risk of coronary artery disease progression and acute events. The nature and drivers of these persistent regional inequalities, and their structural determinants in terms of risk factor prevalence, healthcare access, and socioeconomic disadvantage, are examined in Chapter 2 of this thesis.

Poland's overall position within the European comparative landscape may be characterised as one of substantial but incomplete epidemiological transition. The country achieved remarkable progress in reducing cardiovascular mortality after 1991, driven by a convergence of rapid behavioural change, expansion of modern cardiovascular care, and progressive implementation of evidence-based acute management protocols. Nevertheless, Poland continues to bear a disproportionate cardiovascular burden relative to the European Union average, with remaining challenges concentrated among men, older age groups, and residents of less economically developed regions. These persistent inequalities, and the extent to which they reflect modifiable versus structural constraints, constitute the analytical substance of Chapters 2 and 3 and the evidential basis for the policy recommendations developed in the conclusion of this thesis.

1.4. Methodological Approaches in Mortality Trend Analysis

The analysis of cardiovascular mortality trends requires a systematic understanding of the epidemiological and statistical methods employed to quantify, compare, and decompose changes in mortality rates over time. The selection of appropriate methods is not merely a technical matter but has direct implications for the validity of inferences drawn about the magnitude, pace, and determinants of mortality change; an inappropriate analytical framework can produce systematically misleading conclusions about the extent of epidemiological progress or the factors responsible for observed changes. This section provides a systematic account of the principal analytical tools applied in contemporary research on cardiovascular mortality trends, explaining the conceptual basis, strengths, limitations, and specific applications in the Polish context of each approach. The methods described here provide the analytical backbone for the trend analyses presented in Chapter 3 and are referenced throughout the thesis wherever quantitative evidence on mortality change is assessed and interpreted.

The most fundamental challenge in mortality trend analysis is ensuring that observed changes in death rates reflect genuine shifts in the underlying risk of dying from a given cause, rather than artefacts of demographic change in the study population. Because cardiovascular disease mortality risk rises steeply with age, a population that is ageing will tend to experience increasing crude (unadjusted) cardiovascular death rates even if the age-specific risk of dying from cardiovascular disease has declined at every age. This demographic confounding is directly relevant to Poland, where population ageing has proceeded rapidly — with the proportion of the population aged 65 and over increasing substantially between 1990 and 2020 — making the use of crude death rates a potentially misleading measure of epidemiological progress. Age-standardised death rates (ASDRs) address this problem by applying a standard age structure to the observed age-specific mortality rates of the study population, yielding a synthetic rate that reflects what the crude death rate would be if the population had the same age distribution as the standard reference population, thereby enabling valid temporal and cross-national comparisons independent of demographic composition.

Direct standardisation, the most commonly employed approach in European health statistics, calculates the ASDR by multiplying the age-specific death rates observed in the study population by the corresponding proportions of the standard reference population in each age group, and summing the products. Two standard populations are most frequently applied in European cardiovascular mortality research: the European Standard Population 2013, developed by Eurostat to reflect the contemporary European Union age structure and now the recommended standard for European health statistics; and the WHO World Standard Population, which applies a younger and more demographically diverse reference structure appropriate for global comparisons. The transition from the Old European Standard Population, used in much of the pre-2013 research literature, to the European Standard Population 2013 can produce apparent discontinuities in ASDR time series, as the two standards assign different weights to age groups with different mortality risks, and this methodological shift must be taken into account when comparing studies published across this transition period. Indirect standardisation, yielding Standardised Mortality Ratios, is employed when the study population is small and age-specific death rates in subcategories are statistically unstable, but is less suitable for long-term trend analysis because Standardised Mortality Ratios are reference-population-dependent and therefore not directly comparable across geographic units or successive reference periods.

Joinpoint regression has emerged as the standard statistical method for identifying significant changes in mortality trend direction and has been widely applied to the analysis of cardiovascular mortality trends in Poland and across Europe. The technique models a time series of age-standardised death rates on a logarithmic scale — to stabilise variance and model multiplicative rather than additive change — as a series of connected linear segments, with the number and location of segments estimated from the data using a permutation-based hypothesis testing procedure that controls the overall false-positive rate. The primary outputs include the estimated locations of joinpoints — time points at which the trend slope changes significantly — and the annual percentage change for each inter-joinpoint segment. The average annual percentage change (AAPC), computed as the geometric mean of individual segment APCs weighted by their duration, provides a single summary measure of overall trend magnitude across the entire study period, facilitating comparison between populations, sex groups, or disease categories. Applied to acute myocardial infarction mortality in Poland, this framework demonstrated an AAPC of −5.6 per cent in age-standardised death rates over 2000–2023, with the analysis additionally identifying the 2017–2020 period as a statistically significant segment of stagnation separating distinct trend phases.

• Age-standardised death rates: the primary metric for valid temporal and cross-national mortality comparison; computed by direct standardisation applying the European Standard Population 2013 or WHO World Standard Population to observed age-specific death rates
• Joinpoint regression: statistical identification of significant changes in trend slope within a mortality time series, yielding annual percentage change and average annual percentage change estimates characterising trend magnitude and direction across defined segments
• Potential Years of Life Lost (PYLL) and Standard Expected Years of Life Lost (SEYLL): summary measures of premature mortality burden weighting deaths at younger ages more heavily; SEYLL uses life-table-derived expected years of remaining life rather than a fixed reference age ceiling, producing a measure sensitive to gains at all ages
• Decomposition analysis: statistical technique partitioning changes in all-cause mortality or life expectancy into contributions attributable to specific age groups and cause-of-death categories, enabling attribution of aggregate mortality change to its demographic and epidemiological components
• Multiple-cause mortality analysis: examination of death certificate data in which cardiovascular disease is sought anywhere on the certificate, providing a broader estimate of cardiovascular mortality burden than the standard underlying-cause framework, particularly relevant in multi-morbid elderly populations

The Potential Years of Life Lost indicator and its standardised counterpart SEYLL provide complementary information to age-standardised death rates by quantifying the burden of premature mortality in a manner that reflects societal loss rather than simple death counts. PYLL is calculated by summing, for all deaths below a defined reference age — conventionally 70 or 75 years in most European analyses — the difference between the reference age and the age at death, assigning zero value to deaths occurring at or above the reference. SEYLL extends this concept by using life-table-based expected years of remaining life at each age rather than a fixed ceiling, producing a measure sensitive to survival improvements across all ages below the reference and adaptive to changes in background life expectancy over the study period. Applied to Polish AMI mortality data, SEYLL analysis has documented a reduction of more than 70 per cent between 2000 and 2023, from 608,488 to 191,476 standard expected years of life lost, with the SEYLL per death declining from 21.2 to 16.9 years — a finding indicating not only fewer deaths but an older age at cardiovascular death, consistent with effective secondary prevention extending survival after myocardial infarction without fully preventing eventual fatal recurrence.

Decomposition analysis provides a third analytical perspective by attributing changes in overall mortality or life expectancy between two time points to specific age groups and cause-of-death categories. The Arriaga decomposition method, widely applied in the analysis of European cardiovascular mortality trends, partitions the difference in life expectancy at birth between two periods into age-specific components, which can be further disaggregated by cause of death using a multiplicative approach. This technique addresses the question of how much of the change in overall life expectancy between two measurement periods is attributable to changes in cardiovascular disease mortality, and within that, at which ages the contribution is greatest. Applied to Central and Eastern European mortality data in comparative epidemiological analyses — including research within the framework of the HAPIEE study — decomposition has consistently demonstrated that reductions in cardiovascular mortality at middle ages (approximately 45–74 years) have been the principal driver of life expectancy improvements across the region since the early 1990s, while cardiovascular mortality at older ages has remained a more persistent source of excess burden relative to Western European benchmarks. This finding identifies middle-aged cardiovascular mortality as the pivotal target for further policy intervention in countries where Western European life expectancy levels represent the aspirational benchmark.

The reliability of cardiovascular mortality trend analysis is critically dependent on the quality of the underlying vital registration data, which is in turn a function of the completeness of death registration, the accuracy of cause-of-death certification by physicians, and the consistency of nosological coding applied by statistical personnel. In Poland, the vital registration system is considered to be of high completeness, with adult death registration rates estimated above 99 per cent, ensuring that mortality time series are not substantially distorted by systematic under-registration. However, the accuracy of cause-of-death attribution presents persistent challenges. Studies across European health systems have documented systematic variation in physician completion of death certificates, including a tendency towards over-attribution of deaths to heart failure as the underlying cause — when the primary condition initiating the fatal sequence is ischaemic heart disease — and differential use of unspecified stroke codes (I64) versus specific haemorrhagic and ischaemic subtypes, with the unspecified code accounting for a disproportionate share of stroke deaths in health systems where computed tomography availability is limited. These coding patterns can affect the apparent magnitude of trends in specific cardiovascular subcategories even when the overall cardiovascular mortality trend is accurately captured. The introduction of automated coding systems such as IRIS, and ongoing training programmes for physicians in cause-of-death certification, have been implemented across European health systems including Poland to improve certification quality and coding consistency over time.

The methodological issue of ICD revision transitions is of particular significance for the analysis of Polish cardiovascular mortality data spanning the period from the early 1990s to the present. Poland adopted ICD-10 for mortality coding in 1997, having previously used ICD-9, and this transition introduced changes in the classification of several important cardiovascular conditions — including modifications to the coding of heart failure subtypes, changes in the categorisation of specified versus unspecified stroke, and adjustments to the selection rules for underlying cause of death in the presence of multiple conditions — that can produce apparent discontinuities in mortality time series which do not reflect genuine changes in mortality risk. The standard methodological response involves the construction and application of bridge coding tables, which allow the calculation of revision-specific correction factors applicable to pre-transition data, enabling the construction of comparable long-term time series spanning the ICD revision boundary. For the trend analyses presented in Chapter 3 of this thesis, bridge coding adjustments available for the ICD-9 to ICD-10 transition in Polish cardiovascular mortality data are applied to pre-1997 data points to ensure the validity of comparisons across the full study period, and the methodological choices made are documented transparently to enable critical appraisal. The progressive implementation of ICD-11, with its updated nosological categories and revised coding conventions for several cardiovascular conditions, represents the next methodological challenge confronting researchers in this field and will require similar bridging strategies to maintain the continuity of long-term trend analyses as national health information systems migrate to the new revision.

Chapter 2. Determinants and Risk Factors of Cardiovascular Mortality in the Polish Population

The elevated burden of cardiovascular mortality in Poland cannot be attributed to any single cause but reflects the convergent influence of multiple determinants operating at distinct levels of the causal hierarchy. Individual behavioural choices, metabolic dysregulation, socioeconomic circumstances, and the structural features of the healthcare system each contribute to the overall burden of fatal cardiovascular events in ways that are both independent and mutually reinforcing. The analysis presented in this chapter proceeds from proximate behavioural and metabolic risk factors to more distal socioeconomic and systemic determinants, following the established logic of the Dahlgren–Whitehead rainbow model of health determinants, which conceptualises individual lifestyle factors as embedded within broader social, cultural, and structural contexts.<sup>[13, s. 1859]</sup> Understanding this multilevel architecture of cardiovascular risk is essential not only for interpreting the historical mortality trends discussed in Chapter 3 but also for evaluating the potential effectiveness of prevention and treatment strategies aimed at further reducing the burden of premature cardiovascular death in the Polish population.

2.1. Modifiable Behavioural Risk Factors

Behavioural risk factors occupy a central position in the epidemiology of cardiovascular mortality, as they represent the primary preventable contributors to premature cardiovascular death at the population level. The Global Burden of Disease (GBD) 2019 study estimated that the four principal modifiable behavioural determinants — tobacco smoking, physical inactivity, unhealthy dietary patterns, and excessive alcohol consumption — collectively accounted for the largest proportion of attributable cardiovascular mortality in Central and Eastern Europe, surpassing metabolic risk factors when considered in isolation. In Poland, the epidemiological salience of these factors reflects decades of unfavourable behavioural patterns rooted in post-war cultural habits, which began to shift significantly only from the early 1990s onward under the combined influence of market liberalisation, public health campaigns, and legislative interventions. The investigation of these behavioural determinants draws upon several national epidemiological surveys — most notably the NATPOL (Nationwide Survey of Cardiovascular Risk Factors), WOBASZ (Multi-Centre National Population Health Examination Survey), and PolSenior studies — as well as comparative data from Eurobarometer surveys, the World Health Organization Global Health Observatory, and the European Cardiovascular Disease Statistics published by the European Society of Cardiology.

Tobacco smoking constitutes arguably the most extensively documented behavioural cardiovascular risk factor, and Poland's historical experience with smoking is particularly instructive. From the 1960s through the 1980s, Poland exhibited some of the highest cigarette consumption rates in Europe, with prevalence among adult men estimated at approximately 60–70% during peak periods.<sup>[14, s. 4]</sup> This sustained exposure contributed substantially to the excess cardiovascular mortality observed in Poland relative to Western European comparators, particularly through mechanisms of endothelial dysfunction, accelerated atherogenesis, enhanced platelet aggregability, and unfavourable alterations in plasma lipid profiles. A marked decline in male smoking prevalence began in the late 1980s and accelerated following the enactment of the 1995 Act on the Protection of Health from the Consequences of Using Tobacco and Tobacco Products, which introduced restrictions on advertising, requirements for health warnings on packaging, and limitations on smoking in public spaces. A further strengthening of tobacco control legislation occurred with the 2010 amendment introducing comprehensive bans on smoking in enclosed public places, consistent with the requirements of the WHO Framework Convention on Tobacco Control. Successive NATPOL surveys documented a decline in daily smoking prevalence among Polish men from approximately 48% in 1997 to around 33% in 2011. Female smoking trends proved more complex: whereas male prevalence declined substantially, female prevalence remained comparatively stable or declined less markedly, with NATPOL 2011 recording daily smoking among approximately 21% of adult Polish women, reflecting the later adoption of smoking habits by women and the lagged impact of tobacco control measures on female cohorts.

Physical inactivity represents a second major behavioural risk factor whose contribution to cardiovascular mortality in Poland has been consistently documented across multiple survey instruments. Eurobarometer data on sport and physical activity in European Union member states have persistently placed Poland among the more sedentary populations: surveys conducted in 2013 and 2017 reported that approximately 52–57% of Polish adults declared they never engaged in sport or physical exercise, compared to EU averages in the range of 40–45%.<sup>[15, s. 76]</sup> The NATPOL 2011 study similarly identified substantial proportions of the adult Polish population failing to meet the World Health Organization recommendation of at least 150 minutes of moderate-intensity aerobic physical activity per week, with particularly pronounced insufficiency among older adults, women, rural residents, and persons of lower socioeconomic status. The biological pathways through which sedentary behaviour exacerbates cardiovascular risk are multiple and well-characterised: reduced physical activity is associated with impaired insulin sensitivity, adverse lipid profiles characterised by elevated triglycerides and reduced high-density lipoprotein cholesterol, heightened systemic inflammation, unfavourable haemodynamic loading of the left ventricle, and accelerated progression of atherosclerotic plaque. The transition from predominantly physically demanding agricultural and industrial labour toward more sedentary service-sector employment over the period of rapid economic transformation in Poland from the 1990s onward represents an important structural driver of increasing population-level physical inactivity, partly counterbalancing cardiovascular benefits accruing from improved nutrition and healthcare access.

Dietary patterns in the Polish population have historically been characterised by a constellation of features unfavourable to cardiovascular health. National nutrition surveys, including the 2016 Individual Food Consumption Study conducted by the National Food and Nutrition Institute (Instytut Żywności i Żywienia), documented a dietary profile featuring high consumption of saturated fatty acids — primarily from animal sources including lard, fatty pork products, and full-fat dairy — refined carbohydrates, processed meat products, and sodium, the last mediated both by direct salt addition and by the high salt content of cured and pickled foods traditional to Polish culinary culture. Insufficient intake of protective dietary components — including fruits, vegetables, legumes, wholegrain cereals, and marine-derived omega-3 fatty acids — further characterised the national dietary pattern. This dietary profile promotes cardiovascular risk through multiple pathways: high saturated fat intake drives elevation of low-density lipoprotein cholesterol and systemic inflammation; excessive sodium consumption raises blood pressure through volume-expansion mechanisms; insufficient fruit and vegetable intake reduces the availability of antioxidants, potassium, and dietary fibre; and low omega-3 fatty acid intake deprives the myocardium and vascular endothelium of their anti-inflammatory and anti-arrhythmic effects. Measurable shifts in dietary patterns from the early 1990s onward — driven partly by market liberalisation and partly by public health education — suggest reductions in animal fat consumption and increases in fruit and vegetable intake; however, the pace of dietary change has been insufficient to eliminate the diet-attributable component of cardiovascular risk at the population level.

Alcohol consumption represents a fourth behavioural dimension of cardiovascular risk with particular features in the Polish context. Data from the State Agency for the Prevention of Alcohol-Related Problems (Państwowa Agencja Rozwiązywania Problemów Alkoholowych — PARPA) and the WHO Global Health Observatory place Poland's per-capita pure alcohol consumption among adult males in the range of 14–17 litres per year in the 2010s, above the European Union average. The relationship between alcohol intake and cardiovascular risk follows a non-linear pattern: low-to-moderate consumption has been associated in observational studies with modest cardioprotective effects relative to abstinence, mediated through increases in high-density lipoprotein cholesterol and mild anti-platelet effects. However, heavy and episodic binge drinking — characteristic patterns well-documented in Polish men — are associated with substantially elevated cardiovascular risk. Heavy alcohol intake is an established cause of dilated alcoholic cardiomyopathy, a condition of progressive impaired left ventricular contractility that may progress to heart failure and sudden cardiac death. Episodic binge drinking is associated with the so-called holiday heart syndrome — acute onset of atrial fibrillation or other supraventricular arrhythmias in individuals without structural heart disease — and with acute haemodynamic perturbations that can precipitate myocardial infarction through catecholamine surges and haemoconcentration-induced thrombosis risk. Stroke risk is additionally elevated with heavy consumption, particularly haemorrhagic stroke through hypertensive crisis mechanisms.

Table 2.1. Principal modifiable behavioural risk factors for cardiovascular mortality in Poland: estimated prevalence and temporal trends, 1990s–2010s

Risk Factor	Estimated Prevalence (early 2010s)	Temporal Trend (1990–2015)	Primary Cardiovascular Mechanisms
Tobacco smoking (daily)	~33% men; ~21% women (NATPOL 2011)	Marked decline in men; modest decline in women	Endothelial dysfunction, atherogenesis, thrombosis
Physical inactivity (below WHO guidelines)	~52–57% of adults (Eurobarometer 2013)	Increasing with occupational sector shift	Insulin resistance, dyslipidaemia, cardiac remodelling
Unhealthy dietary pattern	Widespread; excess saturated fat and sodium	Gradual improvement since 1990s	Hypercholesterolaemia, hypertension, inflammation
Excessive alcohol consumption	~14–17 L per capita/year in men (PARPA, WHO)	Stable to slightly decreasing	Cardiomyopathy, arrhythmia, haemorrhagic stroke

A further dimension of analytical importance concerns the phenomenon of behavioural risk factor clustering — the established tendency for multiple adverse lifestyle behaviours to co-occur within the same individuals and social subgroups, rather than distributing independently across the population. Epidemiological evidence consistently demonstrates that tobacco smoking, physical inactivity, poor diet, and excessive alcohol consumption are positively intercorrelated at the individual level, and that this clustering is strongly patterned by socioeconomic position: individuals with lower educational attainment, lower income, and lower occupational status are simultaneously more likely to smoke, to be physically inactive, to consume nutritionally poor diets, and to engage in hazardous alcohol consumption. The cardiovascular risk associated with multiple simultaneous behavioural risk factors is not simply additive but multiplicative: the joint presence of tobacco smoking and dyslipidaemia, for example, produces a relative risk of cardiovascular events substantially exceeding the product of the individual relative risks. This clustering dynamic means that socially disadvantaged subgroups in Poland carry a disproportionate and amplified cardiovascular risk burden through their concentration of behavioural risk factors, contributing to the socioeconomic gradients in cardiovascular mortality documented in Section 2.3. Population-attributable fractions estimated by GBD 2019 analyses for the combined contribution of these four behavioural risk factors to total cardiovascular mortality in Poland exceeded those observed in Western European populations, reflecting both the higher absolute prevalence of smoking and physical inactivity and the less favourable dietary profile of the Polish adult population.

2.2. Metabolic and Clinical Risk Factors

Metabolic and clinical risk factors represent the intermediate causal layer between upstream behavioural determinants and downstream fatal cardiovascular events. They are characterised by pathophysiological alterations — in blood pressure, lipid metabolism, glucose homeostasis, and adipose tissue mass — that directly damage arterial walls, impair myocardial perfusion, and destabilise haemostatic balance, thereby elevating the risk of acute coronary syndromes, stroke, and sudden cardiac death. In the Polish population, the prevalence and control status of these intermediate risk factors have been characterised through the NATPOL survey series, the WOBASZ study (2003–2005) and its follow-up WOBASZ II (2013–2014), and the PolSenior study examining the older population. The convergent findings of these surveys paint a picture of a population with high but gradually improving metabolic risk profiles, against the backdrop of expanding pharmacological treatment capacity and slowly shifting lifestyle patterns.

Arterial hypertension constitutes the single largest modifiable risk factor for stroke — the primary cerebrovascular cause of cardiovascular death — and a major independent contributor to myocardial infarction, heart failure, and renal failure through sustained pressure overload on the left ventricle and accelerated atherogenesis in large and medium-calibre arteries. The NATPOL 2011 survey estimated the prevalence of arterial hypertension (defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or current antihypertensive pharmacotherapy) at approximately 32% of the Polish adult population aged 18–79 years, representing approximately nine million individuals. Despite steady growth in both awareness of hypertension status and pharmacological treatment uptake — with treatment rates rising from approximately 55% of hypertensive individuals in NATPOL 1997 to approximately 67% in NATPOL 2011 — the proportion of treated hypertensive patients achieving guideline-recommended target blood pressure values below 140/90 mmHg remained critically low, estimated at only approximately 26% of all hypertensive individuals. This situation of high treatment coverage combined with poor blood pressure control stands in sharp contrast to outcomes in Western European countries such as Germany, France, or Scandinavia, where control rates in treated patients have been reported at 50–60%.<sup>[16, s. 7]</sup> The mechanistic explanation for this paradox involves multiple factors: suboptimal antihypertensive regimen intensity with insufficient use of combination therapy, non-adherence to prescribed medications driven by polypharmacy complexity and cost considerations, persistent overconsumption of sodium and alcohol, insufficient weight management, and inadequate lifestyle modification counselling in primary care consultations.

Dyslipidaemia — particularly elevated concentrations of low-density lipoprotein (LDL) cholesterol and total cholesterol, and reduced high-density lipoprotein (HDL) cholesterol — represents a central metabolic driver of atherosclerotic plaque formation and the associated risk of acute cardiovascular events. The WOBASZ II study, conducted in 2013–2014 in a nationally representative sample of Polish adults, documented that approximately 61% of adult men and 57% of adult women had total cholesterol concentrations at or above 5.0 mmol/L. Elevated LDL-cholesterol concentrations above 3.0 mmol/L were particularly prevalent among middle-aged Polish men, while low HDL-cholesterol represented an additional component of atherogenic dyslipidaemia. Temporally, WOBASZ data from 2003–2005 compared with WOBASZ II from 2013–2014 demonstrated a measurable decline in mean total cholesterol concentrations in Polish adults — attributable in part to dietary changes including reductions in animal fat consumption, and in part to the rapid expansion of statin prescribing following the inclusion of statins in the National Health Fund reimbursement schedule. The contribution of declining LDL-cholesterol concentrations to the observed reduction in ischaemic heart disease mortality in Poland over this period is consistent with the findings of decomposition analyses of cardiovascular mortality trends in high-income countries, which attributed a substantial fraction of declining myocardial infarction mortality to improvements in lipid management.

Type 2 diabetes mellitus exerts a uniquely potent influence on cardiovascular mortality risk, operating through mechanisms that are both more numerous and more complex than those of hypertension or dyslipidaemia considered independently. Endothelial dysfunction induced by chronic hyperglycaemia and the associated glycation of proteins in the vascular wall accelerates atherosclerotic plaque formation; concurrent activation of inflammatory pathways through advanced glycation end-products amplifies the inflammatory component of plaque instability; prothrombotic coagulation changes — including elevated fibrinogen, elevated plasminogen activator inhibitor-1, and enhanced platelet aggregability — increase the risk of plaque rupture-associated thrombosis; and autonomic neuropathy impairs the capacity for rapid haemodynamic compensation during ischaemic episodes, increasing the likelihood of lethal arrhythmias. The NATPOL 2011 study estimated the prevalence of known type 2 diabetes mellitus in the Polish adult population at approximately 7–8%, with a further 5–6% estimated to have undiagnosed diabetes on the basis of fasting glucose measurements performed during survey examinations. Individuals with diabetes face approximately two to four times the absolute cardiovascular risk of non-diabetic individuals with otherwise comparable risk factor profiles, and diabetes substantially attenuates the sex-based difference in cardiovascular risk, with diabetic women approaching the elevated absolute risk otherwise characteristic of men.

Obesity and overweight represent metabolic risk factors whose cardiovascular consequences operate through multiple pathways, both directly — through haemodynamic and structural effects on the cardiovascular system — and indirectly, through the promotion of hypertension, dyslipidaemia, and type 2 diabetes. Research on obesity as a cardiovascular risk factor has documented a comprehensive array of adverse effects. The relationship between body mass index (BMI) and blood pressure risk has been quantified as an increase of approximately 5% in hypertension risk per 1 kg/m² increment in BMI in men, and 7% in women, with hypertension occurring two to three times more frequently in obese than in normal-weight individuals <sup>[5, s. 168]</sup>. The risk of heart failure is similarly elevated, with each 1 kg/m² increment in BMI associated with a 5% increase in heart failure risk among men and 7% among women, and five-year mortality among obese patients with established heart failure documented at approximately 50% . Obesity additionally predisposes to the development of atrial fibrillation through mechanisms related to epicardial adipose tissue accumulation around the atria and left atrial enlargement, with the risk of atrial fibrillation among obese individuals estimated at approximately twice that of persons with normal body weight <sup>[5, s. 170]</sup>. Thromboembolic complications represent a further cardiovascular consequence, mediated through elevated concentrations of fibrinogen, coagulation factors VII and VIII, and plasminogen activator inhibitor-1, together with increased platelet aggregability <sup>[5, s. 171]</sup>. The risk of stroke is elevated in proportion to BMI: overweight individuals face an approximately 22% higher probability of stroke relative to persons with normal body weight, a proportion rising to 64% in obese individuals, and each 1 kg/m² increment in BMI is associated with a 4% higher risk of ischaemic stroke and a 6% higher risk of haemorrhagic stroke .

In the Polish population context, the prevalence of overweight and obesity has followed an upward trajectory across successive national surveys. By the early 2010s, the prevalence of obesity (BMI ≥30 kg/m²) among Polish adults was estimated at approximately 24% in men and 25% in women according to NATPOL 2011, with substantially higher prevalence of overweight (BMI 25.0–29.9 kg/m²) bringing total excess weight to affect roughly two-thirds of adult men and more than half of adult women. The epidemiological relevance of central (abdominal) obesity — quantified through waist circumference — as a particularly potent predictor of metabolic syndrome and cardiovascular risk independent of overall BMI deserves particular emphasis, as the accumulation of intra-abdominal visceral fat exhibits metabolic consequences substantially more adverse than subcutaneous fat at equivalent BMI, including more pronounced insulin resistance, more atherogenic lipid profiles, and greater systemic inflammatory activity. The growing obesity burden in Poland was not limited to the adult population; in research focusing on childhood obesity across highly developed societies, Sopińska and colleagues documented that excess body weight in children and adolescents constitutes an established risk factor for cardiovascular diseases — a finding with important implications for the future trajectory of population-level cardiovascular risk in the coming decades <sup>[8, s. 406]</sup>. Metabolic syndrome — defined by the presence of three or more components encompassing central obesity, elevated fasting plasma glucose, elevated serum triglycerides, reduced HDL-cholesterol, and elevated blood pressure — was estimated to affect approximately 20–25% of the adult Polish population in the early 2010s, with prevalence rising markedly with advancing age and showing strong inverse associations with educational attainment and socioeconomic status. The cardiovascular risk associated with the full metabolic syndrome phenotype substantially exceeds the sum of its individual component risks, reflecting pathological synergism between the mechanisms simultaneously engaged by the syndrome's constituent elements.

Metabolic Risk Factor	Estimated Prevalence — Polish Adults (early 2010s)	Treatment / Control Status
Arterial hypertension	~32% (NATPOL 2011)	~67% treated; ~26% at target (<140/90 mmHg)
Hypercholesterolaemia (TC ≥5.0 mmol/L)	~61% men; ~57% women (WOBASZ II)	Improving with statin expansion; control suboptimal
Type 2 diabetes mellitus	~7–8% diagnosed; ~5–6% undiagnosed (NATPOL 2011)	Glycaemic control suboptimal in significant proportion
Obesity (BMI ≥30 kg/m²)	~24% men; ~25% women (NATPOL 2011)	Lifestyle-based intervention; pharmacological options limited
Metabolic syndrome	~20–25% of adults; higher in older age groups	Multifactorial management required

2.3. Socioeconomic and Demographic Determinants

Socioeconomic and demographic factors constitute the structural substrate within which individual behaviours and metabolic risk profiles are embedded, shaped, and reproduced across social strata and population subgroups. The theoretical grounding for this analytical layer derives from the social determinants of health framework elaborated by the World Health Organization Commission on Social Determinants of Health, which documented systematically that the circumstances in which people are born, grow, live, work, and age — including income distribution, educational opportunity, occupational structure, housing, and neighbourhood environments — exert causal influences on health outcomes that are quantitatively comparable to, and often larger than, those of conventional biomedical risk factors. In the Polish context, the Dahlgren–Whitehead rainbow model is particularly apt, as it situates individual lifestyle factors within concentric layers of social influence extending to the structural political and economic conditions that determine the overall distribution of social position. The cardiovascular mortality evidence from Poland demonstrates pronounced and persistent socioeconomic gradients that are not reducible to differences in individual behavioural choices, but reflect the systematic concentration of risk-promoting conditions across entire social strata.

Socioeconomic status (SES), operationalised through income, educational attainment, and occupational class, is associated with cardiovascular mortality through multiple pathways operating simultaneously at the biological, behavioural, and access-to-care levels. Income-gradient analyses of cardiovascular mortality data from the Central Statistical Office (Główny Urząd Statystyczny — GUS) and the National Institute of Public Health (Narodowy Instytut Zdrowia Publicznego — NIZP) consistently demonstrate that Poles in the lowest income quintile face standardised cardiovascular mortality rates approximately two to three times higher than those in the highest income quintile, with this gradient particularly pronounced for premature cardiovascular mortality among individuals aged 25–64 years. The mechanisms linking low income to elevated cardiovascular mortality are multiple: material deprivation reduces access to high-quality food, creates chronic psychological stress with documented adverse haemodynamic and neuroendocrine consequences, constrains access to private healthcare consultations that may supplement public sector care, and restricts adherence to pharmacological regimens due to cost barriers even for partially reimbursed medications. Occupational class differences in premature cardiovascular mortality are similarly documented: manual workers, agricultural labourers, and the unemployed carry a disproportionately high burden of cardiovascular death before age 65 relative to professional and managerial occupational classes. Educational attainment operates as a protective factor through its effects on health literacy — with higher-educated individuals demonstrating greater uptake of preventive health behaviours, higher rates of attendance at preventive health examinations, better adherence to recommended cardiovascular medications, and earlier presentation to emergency services at the onset of acute coronary symptoms.

Geographic inequalities in cardiovascular mortality represent one of the most visible structural features of the Polish cardiovascular burden and have been extensively documented in analyses comparing mortality rates by voivodeship and by urban-rural classification. Time-series analysis of age-standardised cardiovascular death rates by administrative region reveals a persistent east–west gradient, with the eastern voivodeships of Podkarpacie, Podlaskie, Lubelskie, and Świętokrzyskie consistently registering higher rates than the western and northern voivodeships and the major urban agglomerations of Mazovia, Pomerania, and Lower Silesia. This geographic pattern is attributable to the interplay of multiple structural factors: differential access to cardiology departments, catheterisation laboratories, and cardiac surgery centres concentrated predominantly in larger cities; disparate levels of healthcare utilisation, with rural populations making fewer outpatient cardiology consultations relative to urban populations even when access is nominally equal; and structural differences in the socioeconomic risk profiles of regional populations, including educational composition, income distribution, and unemployment rates. The urban-rural dimension of cardiovascular mortality inequality deserves particular elaboration. Rural populations in Poland face specific structural disadvantages in cardiovascular care: higher rates of uncontrolled hypertension, lower uptake of statin therapy despite comparable clinical indication, and longer median ambulance response times to acute coronary syndromes and stroke — with evidence that rural patients reach primary percutaneous coronary intervention centres within the guideline-recommended 90-minute window substantially less frequently than urban patients. Paradoxically, rural populations sometimes demonstrate nominally lower prevalence of certain cardiovascular risk factors — lower rates of measured obesity in some surveys, higher levels of occupational physical activity — which suggests that the rural excess in cardiovascular mortality outcomes is not fully explained by a higher burden of conventional risk factors, and that access-to-care deficits make an independent contribution to the rural mortality gap.

• Income gradient: Poles in the lowest income quintile face cardiovascular mortality rates approximately two to three times those of the highest income quintile, as documented in GUS mortality statistics.
• Occupational class: manual workers and the unemployed experience disproportionately elevated premature cardiovascular mortality (ages 25–64) relative to professional and managerial occupational classes.
• Educational attainment: higher educational level is associated with greater health literacy, higher adherence to preventive recommendations, and earlier acute symptom recognition, all of which reduce cardiovascular mortality risk.
• Regional disparities: eastern voivodeships (Podkarpacie, Podlaskie, Świętokrzyskie) consistently register above-average cardiovascular mortality rates; Mazovian and Pomeranian urban agglomerations register below-average rates.
• Urban-rural gap: lower blood pressure control rates, lower statin uptake, and longer ambulance response times in rural communes contribute independently to excess rural cardiovascular mortality.
• Health inequality programmes: POLKARD and successor initiatives explicitly targeted socioeconomic gradients in cardiovascular access, with mixed results attributable to structural barriers that behavioural interventions alone cannot address.

Sex differences in cardiovascular mortality manifest across two distinct dimensions that should not be conflated in epidemiological analysis. Age-specific cardiovascular mortality rates are substantially higher in men than in women across virtually all age groups below approximately 70 years, with Polish men dying from cardiovascular causes at a median age approximately seven to ten years younger than Polish women — a pattern consistent with the protective effect of oestrogens on the vascular endothelium during the premenopausal years. In absolute numerical terms, however, more women than men die from cardiovascular diseases each year in Poland — a finding explained by the substantially greater life expectancy of Polish women (approximately 80 years compared to approximately 73–74 years for men), which produces larger cohorts of elderly women at elevated absolute cardiovascular risk. This distinction has important public health implications: cardiovascular disease is often perceived culturally as a predominantly male problem, leading to underdiagnosis and delayed treatment of acute coronary syndromes in women — a phenomenon documented in Polish emergency cardiology data through longer door-to-ECG times, less frequent referral for primary percutaneous coronary intervention, and lower rates of evidence-based secondary prevention medication use in female post-myocardial infarction patients. The ageing demographic structure of the Polish population functions additionally as a powerful structural amplifier of cardiovascular burden: projections published by GUS indicate a substantial and accelerating increase in the proportion of the population aged 75 years and over over the coming decades, driven by the reaching of advanced age by the large post-war birth cohorts. Since the absolute risk of myocardial infarction and stroke increases exponentially with advancing age, demographic ageing mechanically increases the total number of cardiovascular deaths even if age-specific rates continue to decline — a consideration central to the mortality projections presented in Chapter 3.

2.4. Healthcare System Factors and Access to Cardiovascular Care

The structure and performance of the healthcare system constitute a determinant of cardiovascular mortality outcomes that is conceptually distinct from individual-level risk factors — operating not through the biological pathways of atherogenesis and haemodynamic overload, but through the institutional mechanisms of disease detection, risk factor management, acute event response, and secondary prevention. The analytical framework proposed by Avedis Donabedian — decomposing healthcare quality into structural, process, and outcome dimensions — provides a useful organising principle for this analysis: the structural features of Polish cardiovascular care (facilities, workforce, technology) are assessed alongside the processes of care delivery (guideline adherence, intervention timeliness) and their measurable outcomes (case fatality rates, secondary event rates, and population-level mortality trends). The historical context of healthcare system transformation is essential for understanding the trajectory of cardiovascular care capacity over the study period.

The transition from the Semashko-model, centrally planned state healthcare system toward the social insurance-based framework introduced by the 1999 reform — establishing the National Health Fund (Narodowy Fundusz Zdrowia — NFZ) as the primary payer for publicly funded services — represented a fundamental restructuring of incentive structures, provider financing, and resource allocation.<sup>[17, s. 5]</sup> In the cardiovascular domain, this transition accelerated the development of a market for privately operated diagnostic and specialist services, stimulated investment in advanced cardiovascular technology, and created competitive incentives that drove rapid expansion of interventional cardiology capacity throughout the 2000s. The expansion of percutaneous coronary intervention (PCI) capacity stands as one of the most consequential healthcare system achievements in Polish cardiovascular medicine. Data from the Polish Society of Cardiology (Polskie Towarzystwo Kardiologiczne — PTK) ORPKI (Ogólnopolski Rejestr Procedur Kardiologii Interwencyjnej) registry document the increase in PCI procedures performed annually in Poland from approximately 40,000 in 2000 to over 110,000 by 2015, with a corresponding increase in the number of active cardiac catheterisation laboratories from fewer than 50 to approximately 165 over the same period. This expansion positioned Poland among the European leaders in PCI volume per million inhabitants. The clinical impact is reflected in the progressive reduction in in-hospital case fatality rates for ST-elevation myocardial infarction (STEMI) — the most immediately life-threatening form of acute coronary syndrome — from approximately 15% in the early 1990s to below 5% by 2015 in centres routinely performing primary PCI (pPCI).<sup>[18, s. 2]</sup> The development of the nationwide network of haemodynamic laboratories capable of performing pPCI on a 24-hours-per-day, seven-days-per-week basis — the STEMI network — enabled progressive implementation of the European Society of Cardiology guideline recommendation for pPCI as the preferred reperfusion strategy within 90 minutes of first medical contact, with measurable improvements in door-to-balloon time achievement rates documented across successive years of ORPKI registry data.

Prevention programmes represent the health system dimension most directly targeted at reducing the population burden of cardiovascular risk factors. The National Programme for Prevention and Treatment of Cardiovascular Diseases — POLKARD — implemented across two phases (2003–2008 and 2006–2011) represented the most comprehensive coordinated governmental investment in cardiovascular prevention in Poland's post-communist history. POLKARD objectives encompassed multiple programmatic dimensions: the expansion of hypertension detection and treatment through primary care-based screening; the establishment of a national network of cardiac rehabilitation facilities; the improvement of stroke care through the establishment and accreditation of stroke units; the enhancement of defibrillation capacity through distribution of automated external defibrillators in public spaces; and the strengthening of secondary prevention medication availability. Evaluations documented measurable progress in hypertension awareness and treatment rates and in cardiac rehabilitation infrastructure; however, critical assessments also identified limitations — particularly in primary prevention programme participation rates and the sustainability of achieved improvements beyond the programme's funded duration. The cardiovascular prevention programme implemented through primary care (profilaktyka chorób układu krążenia through the basic healthcare system — POZ) has been evaluated for uptake and effectiveness with documented low participation rates, attributed to insufficient incentive structures for general practitioners and patient awareness deficits.

• PCI network expansion: from approximately 40,000 procedures and fewer than 50 laboratories in 2000 to over 110,000 procedures and approximately 165 laboratories by 2015 (ORPKI registry data).
• STEMI network implementation: nationwide 24/7 pPCI availability; in-hospital STEMI case fatality declining from ~15% (early 1990s) to below 5% (2015) in active intervention centres.
• POLKARD phases (2003–2008, 2006–2011): expansion of hypertension detection in primary care, cardiac rehabilitation network development, stroke unit accreditation, and improved secondary prevention medication accessibility.
• Cardiac rehabilitation: shown to reduce post-MI all-cause mortality by 20–25% in European meta-analyses; coverage in Poland estimated below 30% of eligible post-MI patients in the mid-2010s.
• Primary care prevention programme (POZ-based): low participation rates attributed to insufficient incentive structures for general practitioners and suboptimal patient health literacy.
• Private cardiology sector: estimated at 30–40% of all cardiology consultations in the mid-2010s, reflecting unmet public-sector demand with inequitable access implications.<sup>[19, s. 2]</sup>

The structural fragmentation characterising the interface between primary, ambulatory specialist, and hospital cardiovascular care in Poland represents a persistent systemic obstacle to coordinated and continuous cardiovascular risk management. Primary care physicians serving as the formal gatekeepers to specialist cardiology consultations in the public NFZ system have been constrained by high patient list sizes, short consultation times, and insufficient incentive structures linking remuneration to preventive care processes. Evidence of delayed specialist referrals for patients with multiple cardiovascular risk factors, prolonged waiting times for echocardiography and exercise stress testing in public-sector outpatient settings, and consequent recourse to private-sector diagnostic services — with access stratified by socioeconomic status — has been documented in patient pathway analyses. Healthcare system financing, assessed through NFZ expenditure data, consistently places cardiovascular diseases among the five highest categories of public health expenditure in Poland; however, per-capita investment in cardiovascular disease prevention and primary care remains below the Organisation for Economic Co-operation and Development (OECD) average, reflecting the structural imbalance between curative and preventive spending that characterises health systems with reactive rather than proactive cardiovascular management paradigms.

Cardiac rehabilitation — the structured, multidisciplinary programme of exercise training, risk factor education, psychological support, and optimisation of secondary prevention pharmacotherapy delivered to patients recovering from acute cardiovascular events — represents a health system intervention of well-documented efficacy, with European and international meta-analyses consistently reporting reductions in post-myocardial infarction all-cause mortality in the range of 20–25% among patients completing comprehensive rehabilitation programmes. Despite this evidence base and formal incorporation into clinical guidelines of the Polish Society of Cardiology and the European Society of Cardiology, the coverage of eligible post-infarction patients by cardiac rehabilitation programmes in Poland has been estimated at below 30% in the mid-2010s. Structural barriers to rehabilitation uptake include geographically uneven distribution of facilities concentrated in academic medical centres and larger cities, insufficient inpatient rehabilitation capacity relative to PCI procedure volumes, organisational barriers in the post-hospitalisation referral pathway, and patient-level barriers including transport difficulties and low awareness of rehabilitation benefits. Research examining health behaviours among patients with established cardiovascular disease — including populations with heart failure — has demonstrated that adherence to health-promoting behaviours, including dietary compliance and regular health monitoring, is strongly associated with quality-of-life outcomes, reinforcing the importance of patient education and behavioural support as integral components of comprehensive cardiovascular care <sup>[7, s. 1]</sup>. More broadly, the documented relationships between cardiovascular risk factors — including blood pressure dysregulation, dyslipidaemia, and glycaemic disturbances — and adverse outcomes in broader systemic disease processes further illustrate the far-reaching consequences of inadequate cardiovascular risk factor control at the population level <sup>[6, s. 991]</sup>. The overall assessment of healthcare system factors in shaping Polish cardiovascular mortality thus presents a dual picture: remarkable achievement in acute interventional capacity approaching Western European standards by the mid-2010s, and persistent underperformance in prevention, primary care-based risk factor control, and secondary prevention implementation — particularly cardiac rehabilitation — that maintains a residual mortality burden amenable to reduction through targeted healthcare system investment and organisational reform.

Chapter 3. Trends in Cardiovascular Mortality in Poland – Temporal Analysis and Public Health Implications

3.1. Long-Term Trends in Overall Cardiovascular Mortality (1990–2020)

The analysis of cardiovascular mortality in Poland over the three decades from 1990 to 2020 reveals a complex and multiphase trajectory that reflects the profound socioeconomic, political, and medical transformations experienced by Polish society during this period. At the commencement of the 1990s, Poland was among the European countries with the highest cardiovascular disease burden, a position that reflected the cumulative consequences of decades of inadequate public health infrastructure, high smoking prevalence, unfavourable dietary patterns dominated by animal fats, and limited access to evidence-based pharmacotherapy including antihypertensives and lipid-lowering agents. Cardiovascular diseases constituted the leading cause of death in the Polish population throughout the observation period, with ischaemic heart disease representing the single most prevalent fatal cardiovascular condition and cerebrovascular disease following as the second most significant contributor to total cardiovascular mortality <sup>[9, s. 143]</sup>. In the working-age population, cardiovascular diseases were responsible for one quarter of all deaths, while for those aged above 64 years, they constituted the most common cause of death across all nosological categories <sup>[9, s. 143]</sup>. Premature cardiovascular mortality — deaths occurring before age 65 — continued to be excessively high in Poland compared with other European Community countries throughout the early observation period, a distinction that carried both demographic and economic consequences for the Polish population <sup>[9, s. 143]</sup>.

The epidemiological transition that Poland underwent following the political and economic transformation of 1989–1991 had immediate and measurable consequences for population health and cardiovascular mortality in particular. The liberalisation of food markets, the availability of a wider range of food products including vegetable oils and fresh produce previously less accessible, the influx of Western pharmaceutical products, and the gradual adoption of Western European dietary patterns contributed to a shift in the cardiovascular risk factor profile of the adult Polish population that manifested in declining mortality rates during the first half of the 1990s. This initial phase of rapid decline in cardiovascular mortality occurred concurrently with broadly similar trends observed across several other Central European states that underwent comparable political transitions, while standing in marked contrast to the simultaneous stagnation or deterioration observed in the mortality trajectories of non-reforming post-Soviet states, underscoring the decisive contribution of macroeconomic and social determinants to population cardiovascular health. The pace of this early decline was sufficiently rapid and unexpected to attract the attention of the international epidemiological community, generating considerable scholarly interest in identifying the specific pathways through which political-economic transformation translated into measurable population health gains within a relatively short temporal window.

The trajectory of cardiovascular mortality in Poland over the three decades under examination can be conceptualised as progressing through several distinguishable phases. The first phase, spanning approximately the early to mid-1990s, was characterised by a relatively rapid decline in age-standardised cardiovascular mortality rates, driven primarily by changes in the population-level risk factor profile — particularly dietary fat composition and cholesterol levels — rather than by advances in acute cardiovascular care, which remained comparatively underdeveloped in the Polish context during this period. The second phase, broadly corresponding to the latter half of the 1990s and the first years of the new century, exhibited a deceleration in the rate of decline as the most readily accessible gains from dietary and behavioural improvements were largely captured, and as rising obesity rates and physical inactivity among younger cohorts began to counteract part of the favourable risk factor trends. The third phase, from approximately 2005 onwards, saw a renewed but more gradual decline in cardiovascular mortality, reflecting the progressive impact of structural investments in acute cardiovascular care infrastructure — most notably the expansion of percutaneous coronary intervention networks and the establishment of regional stroke unit systems — as well as the implementation of national cardiovascular prevention programmes. This third phase continued through the remainder of the observation period, though not without interruption, including a period of stagnation observed around 2017 to 2020 followed by renewed declines thereafter <sup>[3, s. 1]</sup>.

The European Society of Cardiology's designation of Poland as a high cardiovascular risk country reflects the persistence of elevated cardiovascular mortality relative to Western European benchmarks throughout the observation period <sup>[9, s. 153]</sup>. Comparative epidemiological analyses consistently documented a mortality gap between Poland and countries such as France, Germany, and the United Kingdom that, while narrowing progressively over the three decades, had not been fully eliminated by the end of the observation window in 2020. This residual excess mortality is attributable to a combination of factors that can be broadly classified into three domains: higher cardiovascular disease incidence in the Polish population, driven by a less favourable risk factor profile relative to Western European norms; suboptimal uptake of evidence-based secondary prevention pharmacotherapy and cardiac rehabilitation; and continuing socioeconomic inequalities in access to preventive and curative cardiovascular healthcare across different population groups and geographic regions. Each of these domains contributed independently to the mortality gap, and the relative weight of their contributions shifted over the observation period as successive policy interventions addressed some dimensions more effectively than others.

The sex-disaggregated pattern of cardiovascular mortality over the three decades exhibits several notable features that require separate consideration from the aggregate trend. Men consistently bore a disproportionately higher age-standardised cardiovascular mortality burden than women throughout the observation period, a differential attributable to higher smoking prevalence, greater exposure to occupational and psychosocial stressors, and substantially lower uptake of preventive cardiovascular health services among men of working age. However, absolute mortality declines were somewhat more pronounced in men than in women in the context of acute myocardial infarction specifically: over the period 2000 to 2023, the average annual percentage change in AMI mortality was estimated at −5.7% for men compared with −5.3% for women . This differential rate of improvement resulted in a modest narrowing of the male-to-female mortality ratio over the observation period, though a substantial and statistically significant gap persisted at the end of the period. The interpretation of this convergence requires care: the greater absolute improvement in male mortality may partly reflect the greater scope for improvement from a higher baseline rather than a genuine narrowing of the underlying sex-related biological and behavioural risk gap.

Table 3.1. Selected indicators of cardiovascular and acute myocardial infarction mortality trends in Poland and European comparators, selected reference periods

Indicator	Poland (2000 or earliest available)	Poland (2022–2023)	European comparator
Age-standardised AMI death rate (per 100,000)	—	33.9 (2022)	EU average: 36.0 (2022)
SEYLL from AMI (total, all ages)	608,488 years (2000)	191,476 years (2023)	>70% reduction 2000–2023
AMI hospital admission rate — men (per 100,000)	256 per 100,000 (Poland, 2009)	—	187 per 100,000 (Denmark, 2004–2008)
AAPC in AMI mortality rate (2000–2023)	Overall: −5.6% per year (p < 0.05); men: −5.7%; women: −5.3%
CVD as proportion of all deaths (Poland)	Approximately 46% of total mortality
SEYLLd (standardised expected years of life lost per AMI death)	21.2 years (2000)	16.9 years (2023)	Decline indicates older age at death

The conclusion that emerges from this long-term analysis is one of substantial but incomplete convergence. Poland achieved meaningful reductions in cardiovascular mortality over the three decades from 1990 to 2020, driven by a combination of dietary and behavioural improvements in the early transition period, subsequent advances in acute cardiovascular care, and the progressive implementation of national prevention programmes. The average annual percentage change in AMI mortality of −5.6% sustained over more than two decades testifies to the genuine and durable nature of this progress . Nevertheless, a residual mortality gap relative to Western European benchmarks persisted throughout the period, reflecting structural weaknesses in the Polish approach to cardiovascular prevention and rehabilitation that are examined in detail in the subsequent subchapters. The precise decomposition of the observed mortality trend into contributions from risk factor improvement versus advances in acute and secondary care treatment is methodologically complex, but the available evidence suggests that both pathways contributed meaningfully to the overall decline, with the relative weight of treatment improvements growing substantially in the post-2003 period as the PCI infrastructure expanded and evidence-based acute care became more uniformly accessible across the Polish territory.

3.2. Cause-Specific Mortality Trends: Ischaemic Heart Disease and Cerebrovascular Disease

The aggregate trend in cardiovascular mortality presented in the preceding subchapter conceals substantial heterogeneity in the dynamics of individual cardiovascular subcategories, of which ischaemic heart disease and cerebrovascular disease constitute by far the most significant contributors to the overall mortality burden. A disaggregated analysis of these two principal causes reveals distinct trajectories, different responsiveness to preventive and therapeutic interventions, and divergent age- and sex-specific patterns that have important implications for attributing observed mortality changes to specific drivers and for targeting future public health resources. Together, these two subcategories accounted for the majority of cardiovascular deaths in Poland throughout the observation period, and their separate analysis is essential to understanding why the overall cardiovascular mortality trend evolved as it did and which interventions merit continued investment in the coming decade.

Ischaemic heart disease, encompassing the spectrum of conditions from stable angina through to acute myocardial infarction, has been identified as the single most prevalent cardiovascular cause of death in Poland throughout the observation period and the principal driver of the overall cardiovascular mortality trend. Acute myocardial infarction represents the most serious and immediately life-threatening manifestation of ischaemic heart disease, and the epidemiological analysis of AMI-specific mortality provides the most rigorously documented case study of cause-specific cardiovascular mortality dynamics in the Polish context. Nationwide analysis of AMI mortality trends using death certificate data spanning over two decades demonstrates a sustained and statistically significant decline in both absolute and age-standardised mortality indicators across the period from 2000 to 2023, with an average annual percentage change of −5.6% (p < 0.05) for the overall Polish population . This rate of decline reflects the combined influence of improvements in AMI incidence — driven by favourable trends in cardiovascular risk factor prevalence, particularly cholesterol levels and smoking rates — and of dramatic advances in AMI treatment, including the progressive expansion of primary percutaneous coronary intervention as the standard of care for ST-elevation myocardial infarction across an increasingly dense network of catheterisation laboratories.

The AMI-PL nationwide database, covering the period 2009 to 2012, provides detailed epidemiological characterisation of AMI incidence and outcomes in Poland during a critical phase of the cardiovascular care transition. Hospital AMI admission rates in Poland during this period were substantially higher than those observed in comparable Western European countries: among men, AMI admission rates reached 256 per 100,000 population in Poland in 2009, compared with 187 per 100,000 in Denmark during 2004 to 2008, a differential of approximately one third; among women, the corresponding rates were 152 per 100,000 in Poland and 116 per 100,000 in Denmark respectively . German admission rates were approximately 10% lower than Polish rates during the same period <sup>[9, s. 153]</sup>. These comparative data have fundamental implications for the interpretation of the AMI mortality gap between Poland and Western Europe: higher mortality due to AMI in Poland results predominantly from higher AMI incidence rather than from inferior acute treatment outcomes, given that AMI treatment and its outcomes have progressively approached Western European standards with advances in cardiac care <sup>[9, s. 155]</sup>. This finding shifts the analytical emphasis decisively towards primary prevention: if the residual excess mortality derives primarily from higher incidence, then intensification of efforts to modify the upstream risk factor burden in the general population represents the highest-yield strategy for further mortality reduction, whereas continued exclusive investment in acute care infrastructure offers progressively diminishing marginal returns.

The sex-specific pattern of ischaemic heart disease mortality is particularly pronounced in the Polish epidemiological context, with men experiencing substantially higher AMI mortality rates than women throughout the observation period, consistent with the well-established male predominance of premature ischaemic heart disease. The rate of decline in AMI mortality was slightly greater for men (average annual percentage change −5.7%) than for women (−5.3%) over the 2000–2023 observation period , indicating that absolute mortality improvements were somewhat more concentrated in the higher-risk male population. Age-specific analysis consistently documents that premature ischaemic heart disease mortality — deaths occurring before age 65 — constitutes a disproportionate contributor to the overall mortality burden and represents the domain in which Poland's excess relative to Western European norms has been most persistent and most clinically significant. The working-age male population, particularly in the 45 to 64 age group, bears the heaviest burden of premature IHD mortality, a pattern linked to higher cumulative smoking exposure, dietary risk factor prevalence, and substantially lower uptake of preventive health services than their female counterparts of comparable age.

Cerebrovascular disease, comprising both haemorrhagic and ischaemic stroke, represents the second major contributor to cardiovascular mortality in Poland and follows a broadly parallel but epidemiologically distinct trajectory. Stroke mortality in Poland declined substantially over the three decades of the observation period, reflecting improvements in hypertension control — the dominant modifiable risk factor for both ischaemic and haemorrhagic stroke — and the progressive development of specialised stroke unit infrastructure with systematic implementation of evidence-based acute stroke management. The pace of decline in cerebrovascular mortality was somewhat slower than that observed for ischaemic heart disease in the early phase of the observation period, reflecting the later maturation of the stroke care infrastructure relative to the more rapidly expanding coronary intervention network. The establishment of dedicated acute stroke units across Polish voivodeships, accelerating under the National Stroke Programme and associated financing instruments, enabled the systematic provision of thrombolytic therapy for eligible ischaemic stroke patients and, subsequently, mechanical thrombectomy for large vessel occlusion — interventions with well-documented reductions in case fatality and permanent disability. The pattern of relative rates of decline between IHD and stroke mortality equalised or partially reversed in the latter part of the observation period as stroke unit coverage achieved broader geographic penetration and as antihypertensive pharmacotherapy uptake improved progressively among hypertensive patients in the primary care system.

• Ischaemic heart disease mortality declined at an average annual rate of −5.6% between 2000 and 2023, with the rate of decline being somewhat greater in men (−5.7%) than in women (−5.3%) .
• AMI hospital admission rates in Poland in 2009 exceeded those in Denmark by approximately one third among men (256 versus 187 per 100,000) and by approximately 31% among women (152 versus 116 per 100,000) .
• The excess AMI mortality in Poland relative to Western Europe derives primarily from higher incidence rather than inferior acute treatment outcomes, a finding with fundamental implications for prevention policy prioritisation <sup>[9, s. 155]</sup>.
• Cerebrovascular disease mortality declined more slowly than ischaemic heart disease mortality in the earlier phases of the observation period, with the pace of stroke mortality reduction accelerating following the broader geographic implementation of stroke unit networks and improved antihypertensive pharmacotherapy access.
• Women bear a disproportionate share of absolute stroke deaths in the Polish population, reflecting their longer life expectancy and the steep age-related increase in stroke risk that places the elderly female population at elevated absolute risk despite lower age-standardised rates.

The contribution of each subcategory to the overall cardiovascular mortality trend exhibits temporal variation reflecting the different stages of maturation of the corresponding treatment and prevention infrastructures. In the early 1990s, both ischaemic heart disease and cerebrovascular disease mortality began declining from their elevated baseline levels, with the initial decline driven primarily by population-level changes in dietary fat composition and associated improvements in cholesterol profiles. The subsequent structural investment in acute cardiovascular care infrastructure — particularly the PCI network expansion under the POLKARD programme — produced disproportionate gains in IHD mortality reduction during the 2000s and early 2010s, while the cerebrovascular component of the overall cardiovascular mortality decline accelerated in the subsequent decade as stroke care achieved broader geographic coverage. By the end of the observation period, both subcategories had achieved substantial mortality reductions from their 1990 baselines, yet Poland's age-standardised mortality rates for both IHD and cerebrovascular disease remained above the EU-27 average, reflecting the persistence of a structural deficit in primary prevention capacity that no investment in acute care infrastructure alone can fully compensate over the medium term.

The regional dimension of cause-specific cardiovascular mortality trends reveals systematic geographic heterogeneity within Poland that maps broadly onto the socioeconomic geography of the country. Voivodeships in eastern Poland consistently exhibit slower rates of decline in both IHD and cerebrovascular disease mortality relative to the more urbanised western and central regions, a pattern attributable to lower density of cardiology and neurology specialist services, greater geographic barriers to accessing acute care facilities within the time windows critical for effective AMI and stroke treatment, higher prevalence of modifiable cardiovascular risk factors, and lower socioeconomic status indicators including educational attainment and household income. These regional disparities represent a persistent equity challenge within the Polish cardiovascular mortality landscape that policy interventions to date have not succeeded in fully addressing, and that is examined further in the context of premature mortality in the subsequent subchapter.

3.3. Premature Cardiovascular Mortality and Years of Life Lost

Premature cardiovascular mortality — conventionally defined as cardiovascular deaths occurring before the age of 65 or 70, depending on the analytical framework employed — constitutes a particularly significant dimension of the cardiovascular mortality burden in Poland, from both a public health and a socioeconomic perspective. The quantification of premature death through the Potential Years of Life Lost metric, or its population-standardised variant the Standardised Expected Years of Life Lost, offers an analytical perspective that differs fundamentally from crude or age-standardised death rates: rather than weighting each death equally regardless of age at occurrence, the PYLL and SEYLL frameworks assign greater weight to deaths at younger ages, thereby making the burden of premature cardiovascular mortality visible in a way that aggregate mortality statistics systematically obscure. This methodological choice has substantive implications for health policy: a health system that successfully reduces cardiovascular mortality predominantly in the oldest age groups achieves a measurable improvement in age-standardised death rates while leaving the burden of premature mortality — and the associated loss of productive life years — comparatively unchanged, an outcome that would not be captured adequately by conventional mortality indicators.

The trend analysis of AMI-related years of life lost in Poland over the period 2000 to 2023 reveals a dramatic and sustained improvement that exceeds in relative magnitude the decline observed in crude mortality rates. The standardised expected years of life lost due to acute myocardial infarction decreased from 608,488 years in 2000 to 191,476 years in 2023, representing a reduction of more than 70% over the observation period . This striking figure reflects not only the decline in the total number of AMI deaths but also a systematic shift towards older age at death among those who did die from AMI: the standardised expected years of life lost per death declined from 21.2 years in 2000 to 16.9 years in 2023 , indicating that the average age at AMI death increased substantially over the period and that a progressively smaller share of AMI deaths occurred among younger individuals. This progressive ageing of the AMI fatality profile reflects the combined effect of improved primary prevention — reducing AMI incidence among younger adults through risk factor modification — and of more effective acute and chronic AMI management that improves survival to older ages and extends the productive life span of patients with established coronary artery disease.

The sex-disaggregated analysis of years of life lost attributable to AMI in Poland documents that declines were observed for both men and women over the observation period, with similar relative reductions in SEYLL across the two sexes <sup>[3, s. 1]</sup>. Men continue to account for the majority of cardiovascular PYLL attributable to premature mortality, reflecting their substantially higher rates of AMI and ischaemic heart disease at younger ages. The male predominance of premature cardiovascular mortality in Poland is particularly pronounced in the age group 45 to 64 years, in which men experience considerably higher cardiovascular death rates than women of comparable age, a differential linked to the complex interaction of biological sex differences in cardiovascular risk with higher smoking prevalence, occupational stressors, and systematically lower uptake of preventive health services among men in this cohort. The narrowing of the male-to-female mortality differential over the observation period — observed in the aggregate cardiovascular mortality data — is an aggregate effect that encompasses both genuine epidemiological improvement and a compositional effect associated with different baseline risk levels, and its interpretation requires caution when projecting future trends.

The temporal pattern of years of life lost over the 2000 to 2023 period was not uniformly progressive. A noteworthy period of stagnation was documented between 2017 and 2020, during which the rate of decline in AMI-related SEYLL slowed substantially before renewed and steep declines were observed in the period following 2020 <sup>[3, s. 1]</sup>. This pattern of stagnation around 2017 to 2020 has also been noted in the United States and other European nations, where it has been attributed to persistent risk factors and systemic pressures on healthcare delivery <sup>[3, s. 11]</sup>. In the Polish context, this stagnation period coincides with a phase of healthcare system strain characterised by workforce shortages, reimbursement pressures on the National Health Fund, and increasing comorbidity burden in the ageing population. The subsequent sharp decline in years of life lost after 2020 may reflect resilience within the Polish healthcare system, though a proportion of this improvement may also reflect the compositional consequences of excess cardiovascular mortality during the COVID-19 pandemic period — the removal from the population of those at highest cardiovascular risk producing an apparent improvement in subsequent SEYLL statistics that does not necessarily represent a durable structural gain .

Trend in Standardised Expected Years of Life Lost (SEYLL) from Acute Myocardial Infarction in Poland, 2000–2023

The figure represents the trajectory of SEYLL attributable to AMI in Poland based on analysis of 431,793 death certificates. SEYLL declined from 608,488 in 2000 to 191,476 in 2023, representing a reduction exceeding 70%. A period of stagnation is evident between 2017 and 2020, followed by renewed and steep declines thereafter. The SEYLLd (years of life lost per death) fell from 21.2 to 16.9 years, indicating a progressive shift towards older age at AMI death. Declines were observed for both men and women, with similar relative reductions across sexes. Source: data from Burzyńska et al. (2026) <sup>[3, s. 1]</sup>.

The regional geography of premature cardiovascular mortality in Poland reflects the socioeconomic and healthcare access inequalities documented elsewhere in this analysis. Voivodeships in eastern Poland — including Podlaskie, Lubelskie, and Podkarpackie — consistently exhibit higher rates of premature cardiovascular mortality and higher cardiovascular PYLL per 100,000 population than the national average, while the metropolitan regions of Warsaw, Wrocław, and the Tri-City demonstrate below-average premature mortality burdens. These regional disparities are not simply a function of differences in age structure or raw disease incidence; they reflect systematic differences in the speed and completeness of implementation of evidence-based cardiovascular prevention and acute care, in the density of specialist cardiology and primary care infrastructure, and in the socioeconomic determinants of cardiovascular risk factor prevalence and health behaviour. The gradient maps broadly onto the general east-west socioeconomic divide within Poland, a pattern that has proven resistant to policy intervention and that constitutes one of the most persistent equity challenges in Polish public health.

The framing of premature cardiovascular mortality through the PYLL lens illuminates an often underappreciated economic dimension of the cardiovascular disease burden. Deaths occurring in the working-age population — particularly in the 45 to 64 age group, which constitutes the core of the economically active Polish workforce — represent not only a social loss of human potential but also a quantifiable economic cost in terms of lost productivity, increased disability payments, reduced tax revenues, and increased burden on caregivers and families. The concentration of premature cardiovascular deaths among men of working age in the economically disadvantaged eastern voivodeships creates a self-reinforcing cycle in which cardiovascular mortality contributes to regional economic underperformance, which in turn sustains the socioeconomic determinants of elevated cardiovascular risk. The remarkable progress demonstrated by the greater-than-70% reduction in AMI-related SEYLL over two decades indicates that this cycle is not deterministic: sustained, appropriately targeted investment in both prevention and acute care infrastructure can produce transformative reductions in premature cardiovascular mortality even within a relatively short epidemiological timeframe, and that potential for further improvement remains substantial given the persisting gaps in primary prevention and cardiac rehabilitation coverage that are documented in the following subchapters.

3.4. The Impact of National Prevention and Health Policy Measures on Mortality Trends

The cardiovascular mortality decline documented in the preceding subchapters did not occur spontaneously: it was shaped, at least in part, by a series of deliberate public health and health system interventions implemented by Polish authorities over the three-decade observation period. Evaluating the causal contribution of specific policy measures to population-level mortality trends is inherently methodologically challenging, given the impossibility of conducting randomised experiments at the population level and the concurrent operation of multiple secular trends — dietary changes, economic development, advances in medical technology — that confound attribution of observed outcomes to specific policy inputs. Nevertheless, a combination of quasi-experimental evidence, comparative analyses exploiting natural policy experiments, and mechanistic reasoning supports the conclusion that several major interventions made material contributions to the observed cardiovascular mortality improvements, even as important implementation gaps and domains of underperformance persist and must be acknowledged in any honest policy assessment.

The National Programme for Prevention and Treatment of Cardiovascular Diseases (POLKARD), implemented in successive iterations from 2003 onwards, represents the most comprehensively documented deliberate cardiovascular health system intervention in the Polish context. The programme's core architecture combined expansion of percutaneous coronary intervention infrastructure — increasing the number and geographic distribution of catheterisation laboratories performing primary PCI for STEMI — with the development of regional stroke unit networks, targeted financing of cardiac rehabilitation programmes, and population-level health awareness campaigns focusing on hypertension and hyperlipidaemia detection and management. Prior to POLKARD, access to primary PCI was concentrated in major urban academic centres, leaving substantial segments of the Polish population — particularly in rural areas and smaller cities — unable to access reperfusion therapy within the time windows that are critical for myocardial salvage and survival improvement. The systematic expansion of the PCI network addressed this structural inequality in acute cardiovascular care access, with the pace of network expansion over the subsequent decade transforming Poland from a country with inadequate acute MI care infrastructure into one where primary PCI coverage approached Western European standards in urban and peri-urban settings.

A more recent and particularly consequential policy innovation in the Polish cardiovascular care landscape is the introduction of coordinated post-acute care programmes for myocardial infarction survivors. Since 2017, the National Health Fund introduced the managed care for acute myocardial infarction survivors — the MACAMIS programme (KOS-Zawał) — as a nationwide structured initiative encompassing acute treatment, complex revascularisation, cardiac rehabilitation, scheduled follow-up visits, and prevention of sudden cardiac death <sup>[3, s. 2]</sup>. Observational analyses of MACAMIS demonstrated substantial survival benefits for participating patients: programme enrolment was associated with a 30% reduction in one-year mortality, corresponding to a hazard ratio of 0.70 (95% confidence interval 0.62–0.80), with the effect persisting beyond the formal programme duration . Importantly, cardiac rehabilitation and structured outpatient care were identified as the most influential individual components of the programme, associated with hazard ratios of 0.34 and 0.42 respectively , establishing that the survival benefit is not homogeneously distributed across programme components but is concentrated in those elements addressing secondary prevention and long-term disease management — precisely the dimensions of cardiovascular care that had been most consistently underutilised in Poland prior to the programme's introduction.

Longer-term evidence supporting the effectiveness of coordinated post-MI care in Poland is provided by the three-year follow-up analysis of the Coordinated Care Programme for patients after myocardial infarction (KOS-MI). The composite endpoint of all-cause death, myocardial infarction, stroke, and repeated revascularisation occurred in 13.7% of patients in the programme group versus 19.3% in the control group at 12-month follow-up (P = 0.02) , demonstrating a clinically meaningful reduction in major adverse cardiovascular events attributable to the coordinated care approach. Hospitalisation due to heart failure decompensation at three-year follow-up was also significantly lower in the programme group (10.4% versus 14.4%; P = 0.0496) , a finding of particular practical importance given the high rate of heart failure hospitalisations in Poland and the associated burden on hospital resources and patient quality of life. These results confirm that the mortality and morbidity benefits of structured coordinated care extend beyond the acute post-MI period and translate into durable reductions in the most costly and clinically serious downstream cardiovascular events.

• The POLKARD national cardiovascular programme, implemented from 2003 onwards, substantially expanded the PCI network across Poland, improving population-level access to primary PCI for ST-elevation myocardial infarction and reducing geographic inequalities in acute cardiovascular care.
• The MACAMIS (KOS-Zawał) programme, introduced in 2017, demonstrated a 30% reduction in one-year post-AMI mortality among enrolled patients (HR 0.70, 95% CI 0.62–0.80), with cardiac rehabilitation (HR 0.34) and structured outpatient follow-up (HR 0.42) identified as the most efficacious programme components .
• Three-year follow-up of the KOS-MI coordinated care programme confirmed significant reductions in MACCE at 12 months (13.7% versus 19.3%; P = 0.02) and in heart failure hospitalisation at 36 months (10.4% versus 14.4%; P = 0.0496) .
• Tobacco control legislation contributed to progressive reductions in adult smoking prevalence across successive cohorts, with inferred cardiovascular mortality benefits following the biological latency period appropriate to ischaemic heart disease and cerebrovascular disease pathogenesis.
• Despite advances in acute care, secondary prevention — particularly cardiac rehabilitation — has remained systematically underutilised in Poland, representing the most clearly identified persisting gap in the cardiovascular care pathway and a major opportunity for further mortality reduction <sup>[9, s. 155]</sup>.

Tobacco control policy represents a second major intervention domain with documented impact on population cardiovascular risk factor profiles. The successive legislative milestones — including the 1995 Tobacco Control Act, subsequent amendments introducing comprehensive indoor smoking bans in workplaces, restaurants, and public transport, and Poland's ratification of the WHO Framework Convention on Tobacco Control — contributed progressively to declining adult smoking prevalence across successive age cohorts. Given the well-established causal relationship between tobacco smoking and ischaemic heart disease and cerebrovascular disease, the sustained decline in smoking prevalence in the Polish adult population can be reasonably inferred to have contributed to the cardiovascular mortality improvements observed over the observation period, with the greatest impact on premature cardiovascular mortality given the concentration of smoking-attributable cardiovascular risk in the working-age population. International evidence from natural policy experiments in Ireland, England, and Scotland — where comprehensive indoor smoking bans were associated with measurable reductions in acute coronary events within months of implementation — supports the plausibility of this causal inference in the Polish context, even in the absence of Polish-specific decomposition analyses of comparable methodological rigour.

The evaluative assessment of policy effectiveness must acknowledge the significant and persistent implementation gap between acute cardiovascular care — in which Poland achieved remarkable advances over the observation period — and secondary prevention, particularly cardiac rehabilitation. The fundamental epidemiological finding that higher mortality due to acute myocardial infarction in Poland results predominantly from higher incidence rather than from inferior acute treatment outcomes — since treatment outcomes have progressively approached Western European standards with advances in cardiac care — indicates a need to intensify primary prevention efforts, while the potential of improvement related to secondary prevention, particularly in the domain of cardiac rehabilitation, has also been substantially underused <sup>[9, s. 155]</sup>. This evidence-grounded assessment encapsulates the central policy challenge: the Polish health system has invested heavily and effectively in interventional capacity but has not achieved comparable results in prevention — primary or secondary — where the remaining potential for further mortality reduction is now greatest and where the cost-effectiveness of additional investment is highest.

3.5. Forecasting Future Trends and Challenges for the Polish Health System

The projection of cardiovascular mortality trajectories for Poland over the coming two decades requires the integration of several interacting forces: the demographic dynamics of an ageing and contracting population, anticipated changes in the prevalence of major cardiovascular risk factors, the trajectory of healthcare capacity expansion and financing, and the potential impact of exogenous disruptions such as pandemic disease or transformative therapeutic innovations. The synthesis of these forces produces a picture of considerable complexity, in which genuinely favourable trends — continued improvements in AMI and stroke treatment quality, progressive adoption of evidence-based secondary prevention — are counterbalanced by structural challenges including demographic ageing, resurging obesity and metabolic risk burden, and persistent healthcare system constraints that have proven resistant to reform across successive political cycles. Any honest forecast must therefore encompass a range of plausible scenarios rather than a single trajectory, acknowledging the genuine uncertainty surrounding the behavioural, institutional, and environmental determinants of future cardiovascular risk.

The demographic dimension of the cardiovascular mortality forecast is perhaps the most analytically tractable, being grounded in established population dynamics rather than in contested behavioural or clinical projections. Poland is currently experiencing an advanced stage of demographic transition characterised by below-replacement fertility, rising life expectancy, and the progressive ageing of the post-war and baby boom cohorts into the highest-risk age categories for cardiovascular disease. The share of the population aged 65 and above is projected to increase substantially over the coming two decades, and since absolute cardiovascular mortality is strongly age-associated — with risk rising steeply from middle age through the eighth and ninth decades of life — this demographic shift alone will generate substantial upward pressure on the absolute number of cardiovascular deaths even in the presence of continued declines in age-standardised mortality rates. The net direction of absolute cardiovascular death counts will be determined by the relative magnitudes of the age-standardised rate decline and the demographic ageing effect: under scenarios of moderate continuing improvement in age-standardised rates consistent with recent trends, absolute cardiovascular deaths may stabilise or increase before eventually declining as the peak ageing cohorts pass through the highest-risk age groups and as primary prevention investments begin to produce mortality benefits in progressively younger cohorts.

Risk factor trend projections produce a notably mixed picture when applied to the Polish population. The epidemiology of obesity and metabolic syndrome in Poland presents a concerning trajectory: prevalence has risen progressively across adult age groups over the past two decades and shows no clear signs of stabilisation, driven by ongoing shifts in dietary patterns towards energy-dense processed foods, declining physical activity levels in increasingly sedentary occupational and recreational environments, and the broadly obesogenic architecture of contemporary urban life. Obesity is a well-established risk factor for all major cardiovascular disease subcategories — ischaemic heart disease, cerebrovascular disease, and heart failure — and modelling studies from comparable European populations project that continued increases in obesity prevalence will attenuate and potentially reverse some of the cardiovascular risk factor gains achieved through improved smoking cessation rates and blood pressure control. Conversely, continued progress in tobacco control — including policies directed at novel nicotine and tobacco products that have partially displaced traditional cigarette smoking among younger cohorts — and the expanding penetration of evidence-based antihypertensive and lipid-lowering pharmacotherapy through primary care will exert countervailing favourable effects on population cardiovascular risk profiles. The net projected effect of these competing trends on cardiovascular mortality will depend critically on whether obesity prevention moves from the margins to the centre of Polish public health policy in the coming decade.

The healthcare system dimension of the forecast reveals a series of structural challenges that, if unaddressed, are likely to limit the Polish health system's capacity to sustain and accelerate the cardiovascular mortality decline of the preceding three decades. Chronic underfunding of the National Health Fund relative to EU-average healthcare expenditure as a share of gross domestic product has persistently constrained the availability and quality of both preventive cardiovascular care and long-term management services for patients with chronic cardiovascular conditions including heart failure and atrial fibrillation — conditions of rising prevalence in the ageing population and associated with high rates of hospitalisation and mortality. Healthcare workforce shortages, particularly in cardiology, internal medicine, and primary care — a long-standing structural deficit in the Polish health system — represent a binding constraint on the scalability of evidence-based cardiovascular prevention programmes and on the expansion of cardiac rehabilitation capacity. Without targeted investment in medical education, remuneration reform, and the organisation of specialist services, the workforce constraint will increasingly limit the impact of even well-designed prevention policies.

Table 3.2. Priority areas for cardiovascular mortality reduction in Poland: challenges, evidence, and policy implications

Priority Area	Principal Challenge	Mechanism of Mortality Impact	Evidence Strength
Cardiac rehabilitation expansion	Systematic underutilisation across Poland; limited geographic coverage outside urban centres	Reduction in post-AMI mortality; HR 0.34 for cardiac rehabilitation component in MACAMIS programme	Strong (programme observational data)
Primary prevention of obesity and metabolic syndrome	Rising prevalence across all adult age groups; absence of effective population-level policy	Reduction in IHD, stroke, and heart failure incidence through improved metabolic risk profile	Strong (epidemiological evidence)
Geographic equity in acute cardiovascular care	Persistent east-west gradient in PCI and stroke unit access	Reduction in case fatality and PYLL through timely acute intervention	Moderate (indirect; regional mortality gradient data)
Primary care-based chronic disease management	Workforce shortage; suboptimal antihypertensive and statin uptake	Improved hypertension and dyslipidaemia control reducing IHD and stroke incidence	Strong (pharmacological evidence; weaker for Polish primary care implementation data)
Post-AMI coordinated care	Incomplete national coverage of KOS-Zawał programme; underenrolment in eligible patients	30% reduction in one-year mortality (HR 0.70) and reduced MACCE at 12 and 36 months	Strong (programme observational data with extended follow-up)

The COVID-19 pandemic constitutes a recent exogenous shock whose long-term consequences for cardiovascular mortality trends remain partially uncertain. The pandemic period of 2020 to 2021 was characterised by documented excess cardiovascular mortality attributable to both direct COVID-19-associated cardiovascular complications and to indirect effects including disruption of elective and emergency cardiovascular care pathways, reduced utilisation of acute coronary care by patients avoiding hospital contact during periods of high infectious disease pressure, and psychological and social stressors with adverse cardiometabolic consequences. The sharp decline in standardised expected years of life lost attributable to AMI observed after 2020 has been noted alongside similar post-stagnation patterns in the United States and other European nations, and its interpretation requires caution <sup>[3, s. 11]</sup>. Future research should focus on identifying population subgroups that benefit least from current prevention strategies, improving uptake of cardiac rehabilitation, and integrating lifetime risk assessment into routine care, with linkage of registry data to clinical and socioeconomic datasets to enhance understanding of long-term AMI outcomes <sup>[3, s. 11]</sup>.

The evidence-informed priority areas for future cardiovascular mortality reduction in Poland that emerge from this synthesis span multiple sectors and require sustained intersectoral commitment extending well beyond the boundaries of the health system. The cardiovascular mortality challenge is simultaneously a healthcare system problem, a food environment problem, an urban planning problem, a health literacy problem, and a social equity problem, and the most effective responses will be those that combine investment in healthcare capacity — expanding cardiac rehabilitation, addressing workforce shortages, extending acute cardiovascular care coverage to underserved regions — with population-level environmental and regulatory interventions that modify the obesogenic and tobaccogenic environments in which Polish residents navigate their health-related choices. The remarkable progress in AMI treatment outcomes achieved over the preceding three decades — to the point where AMI treatment in Poland has become broadly comparable with Western European standards <sup>[9, s. 155]</sup> — demonstrates that deliberate, sustained, and adequately resourced health system investment can produce transformative improvements in cardiovascular mortality at the population level. The imperative for the coming decade is to achieve comparable progress in the prevention domain that has historically lagged behind treatment advances, with secondary prevention and cardiac rehabilitation representing the single most clearly evidenced and immediately actionable priority for policy investment, given the magnitude of the demonstrated mortality benefit and the extent of the documented coverage gap across the Polish population.

Conclusion

The analysis of cardiovascular mortality in Poland conducted across the three chapters of this thesis has demonstrated that the epidemiological trajectory of cardiovascular disease in the Polish population over the three decades from 1990 to 2020 represents one of the most consequential public health transformations in the country's modern history. Beginning from a position among the highest cardiovascular mortality burdens in Europe — a legacy of decades of unfavourable risk factor profiles, limited pharmacotherapeutic availability, and inadequate preventive infrastructure inherited from the socialist health system — Poland achieved a substantial and sustained reduction in age-standardised cardiovascular death rates over the subsequent three decades. This decline was neither uniform in its pace nor equitable in its distribution across the population, and the persistence of significant disparities relative to Western European benchmarks at the close of the observation period underscores the incomplete character of the epidemiological transition and the continued magnitude of preventable cardiovascular mortality in the Polish population.

The drivers of the documented mortality decline were multiple and operated across distinct levels of the causal hierarchy identified in Chapter 2. At the population level, the most consequential contribution to early mortality reduction — particularly evident in the initial phase of decline following the political and economic transformation of 1989–1991 — was attributable to changes in cardiovascular risk factor prevalence, most notably the reduction in tobacco smoking rates and the dietary pattern shift away from animal fat consumption towards plant-based foods and vegetable oils. These behavioural and nutritional changes, driven in part by market liberalisation and in part by evolving health norms, produced reductions in population-mean cholesterol levels and, in conjunction with expanding antihypertensive treatment coverage, contributed to declines in both ischaemic heart disease and cerebrovascular mortality during the 1990s and early 2000s. The historical record thus affirms, for the Polish context, the established epidemiological principle that population-level primary prevention exerts a proportionally greater influence on aggregate cardiovascular mortality than clinical intervention, even as the latter grows in technical sophistication.

The contribution of healthcare system improvements to the overall mortality reduction, while temporally distinct from the earlier behavioural and dietary drivers, was nonetheless substantial and measurable. The expansion of percutaneous coronary intervention capacity across Poland, the development of a coordinated acute myocardial infarction treatment network including catheterisation laboratory coverage extending to previously underserved regions, and the implementation of structured post-infarction care programmes including KOS-MI, collectively transformed acute cardiovascular outcomes to a degree broadly comparable with Western European standards by the mid-2010s. The analysis of standardised expected years of life lost attributable to acute myocardial infarction demonstrated that improvements in acute management translated into meaningful reductions in premature cardiovascular mortality, particularly in the working-age population for whom effective acute intervention has the greatest impact on years of life preserved. The achievement of near-parity with Western European nations in acute cardiovascular interventional capacity represents a genuine and considerable public health accomplishment, reflecting deliberate, sustained, and adequately resourced investment in cardiovascular treatment infrastructure over a compressed time period.

Nevertheless, the thesis has also identified persistent and substantial gaps that prevent the characterisation of Poland's cardiovascular mortality burden as adequately controlled relative to the best-performing European comparators. Age-standardised cardiovascular death rates in Poland remained markedly elevated above the Western European average throughout the observation period, with the absolute differential narrowing but not closing over the three decades examined. These residual disparities were not uniformly distributed across the population: socioeconomic gradients in cardiovascular mortality risk remained pronounced, with individuals of lower educational attainment, lower occupational status, and residents of economically disadvantaged regions — particularly in rural areas and in regions of eastern Poland — carrying a disproportionate share of the preventable cardiovascular burden. Disparities by sex were similarly persistent, with working-age men exhibiting cardiovascular mortality rates substantially exceeding those of women of equivalent age, a differential attributable in part to systematically higher tobacco smoking prevalence and lower preventive care engagement in the male population. These inequalities in the distribution of cardiovascular mortality risk reflect the multilevel determinants framework elaborated in Chapter 2 and indicate that healthcare system investment alone, however effective in improving average outcomes, is insufficient to address disparities rooted in socioeconomic circumstance and health-related behaviour.

The assessment of prevention and treatment strategies undertaken in this thesis reveals a consistent asymmetry between the maturity and effectiveness of treatment-oriented interventions and the relative underdevelopment of preventive approaches, particularly in primary care-based risk factor management and secondary prevention. Cardiac rehabilitation — the most clearly evidenced, cost-effective, and immediately actionable intervention for reducing post-infarction mortality — has been documented as reaching fewer than thirty percent of eligible patients in Poland, a coverage rate that represents a significant failure of secondary prevention implementation and one that is directly amenable to healthcare system intervention without requirement for novel clinical innovation. The underperformance of primary care systems in hypertension detection and treatment, the inadequate pharmacological management of dyslipidaemia at the population level, and the insufficient integration of diabetes management into cardiovascular risk reduction protocols all represent preventable contributors to excess cardiovascular mortality that persist despite the availability of effective and inexpensive interventions. The methodological analysis presented in Chapter 1 further underscores the importance of accurate and consistent mortality data classification for evidence-based policy — the ICD revision transitions and coding practice variations identified as sources of potential artefact in Polish cardiovascular mortality time series highlight the need for sustained investment in cause-of-death certification quality to ensure that epidemiological surveillance accurately reflects population health reality.

On the basis of the evidence synthesised across the three chapters of this thesis, five priority recommendations for public health policy aimed at further reducing the burden of cardiovascular mortality in the Polish population may be formulated. First, the expansion of cardiac rehabilitation coverage should be designated a measurable national health policy objective, with specific targets for the proportion of eligible post-infarction and post-revascularisation patients enrolled in structured rehabilitation programmes within defined timeframes, supported by investment in rehabilitation infrastructure in regions currently underserved by existing facilities. The magnitude of the demonstrated mortality benefit from cardiac rehabilitation, combined with the scale of the documented coverage gap, identifies this as the single most immediately actionable priority with the greatest potential for rapid impact on premature cardiovascular mortality. Second, the strengthening of primary care cardiovascular risk factor management capacity — including systematic hypertension screening, structured dyslipidaemia treatment protocols, and integrated cardiometabolic risk assessment — should be supported through reimbursement reform, workforce training, and digital health record integration that enables population-level monitoring of risk factor control rates. The substantial proportion of hypertensive individuals who remain undiagnosed or inadequately treated in Poland represents a preventable reservoir of future fatal cardiovascular events that primary care intensification could substantially diminish. Third, evidence-based population-level tobacco control measures, including comprehensive smoke-free environment legislation, fiscal measures to reduce tobacco affordability, and sustained public health communication programmes addressing electronic nicotine delivery systems, should be maintained and strengthened, given the continued significance of tobacco exposure as a modifiable contributor to premature cardiovascular mortality, particularly in the male population. Fourth, food environment policies — including mandatory front-of-pack nutritional labelling, reformulation standards for processed food products to reduce saturated fat and sodium content, and fiscal incentives for healthier dietary choices — should be integrated into a coherent cardiovascular prevention strategy that addresses the determinants of dietary behaviour at the population level rather than relying exclusively on individual health education. Fifth, targeted investment in reducing cardiovascular health disparities by socioeconomic status and geographic location should be incorporated into national cardiovascular prevention programmes, with equity impact assessments built into the evaluation frameworks of all major cardiovascular health initiatives to ensure that aggregate improvements in cardiovascular mortality are matched by reductions in the inequality of risk distribution across the Polish population.

In synthesising the evidence presented across this thesis, it is appropriate to acknowledge the limitations inherent in trend analyses of mortality data over an extended observation period. The methodological challenges associated with ICD revision transitions, evolving cause-of-death certification practices, and changes in diagnostic technology over time introduce sources of potential artefact that must be borne in mind when interpreting apparent changes in specific cardiovascular subcategory rates, even where the overall cardiovascular mortality trend is robustly captured. The ecological nature of trend analyses limits the causal inferences that can be drawn about the relative contribution of specific interventions or risk factor changes to the observed mortality trajectory, and the absence of individual-level linked data spanning the full observation period constrains the precision with which socioeconomic gradients in cardiovascular mortality can be characterised. These limitations notwithstanding, the overall picture that emerges from the analysis is sufficiently consistent and coherent to support the conclusions and recommendations offered here with reasonable confidence.

The fundamental conclusion of this thesis is that Poland has achieved a substantial and historically consequential reduction in cardiovascular mortality over the three decades examined, driven by a combination of population-level behavioural change and progressive improvement in healthcare system capacity, but that significant preventable mortality remains — mortality that is concentrated in socially disadvantaged groups, disproportionately attributable to deficiencies in preventive care relative to treatment, and amenable to reduction through evidence-based policy interventions that are known, affordable, and technically feasible. The remarkable progress achieved in acute cardiovascular treatment over the preceding three decades — culminating in interventional capacity broadly comparable with Western European standards — demonstrates that deliberate, sustained, and adequately resourced health system investment can produce transformative improvements in population-level cardiovascular outcomes. The challenge for the coming decade is to achieve comparable progress in the prevention and secondary prevention domains that have historically lagged behind treatment advances, translating the clinical achievements of the past three decades into the broader and more equitably distributed reduction in cardiovascular mortality burden that the Polish population deserves.

List of Tables

1. Table 1.2. Key indicators of acute myocardial infarction and overall cardiovascular mortality in Poland
2. Table 2.1. Principal modifiable behavioural risk factors for cardiovascular mortality in Poland: estimated prevalence and temporal trends, 1990s–2010s
3. Table 3.1. Selected indicators of cardiovascular and acute myocardial infarction mortality trends in Poland and European comparators, selected reference periods
4. Table 3.2. Priority areas for cardiovascular mortality reduction in Poland: challenges, evidence, and policy implications

List of Figures

1. Figure 1.1. Schematic representation of age-standardised cardiovascular mortality trajectories in three European macro-regions and Poland's transitional epidemiological position
2. Figure 2.1. Estimated prevalence and treatment or control status of major metabolic and clinical cardiovascular risk factors in the Polish adult population, early 2010s. Data derived from NATPOL 2011, WOBASZ II (2013–2014), and associated national survey publications. TC = total cholesterol; BMI = body mass index.
3. Figure 3.1. Schematic representation of trends in standardised expected years of life lost (SEYLL) from acute myocardial infarction in Poland, 2000–2023, with indication of the stagnation period 2017–2020 and post-2020 renewed decline